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ABSTRACT
ROLE OF ENVIRONMENTAL FACTORS IN MESENCHYMAL STEM CELL 
BIOLOGY
Sinan Gültekin
M.S. in Molecular Biology and Genetics
Supervisor: Associate. Prof. Dr. K. Can Akçalı
August, 104 Pages
Mesenchymal Stem Cells (MSCs) have the abilities of self-renewal and differentiation into 
fat, bone, cartilage, and muscle tissues. Besides intrinsic mechanisms that control the fate of 
the MSCs, extrinsic physiological factors also play role in this decision. Therefore, our aim is 
to explore the effects of possible environmental factors, involved in MSC maintenance by 
using rat MSCs as a model. We studied the effects of hypoxia and estrogen on growth 
regulation and cellular proliferation in MSCs. MSCs cells exhibited high colony number in 
hypoxic conditions and the expansion of MSCs was increased addition of the estrogen. In 
addition, estrogen prevents apoptosis, under hypoxic condition. The effects of estrogen on the 
expression levels of Notch genes (Notch1, Notch2, Notch3 and Notch4) were also 
investigated. In order to understand the possible mechanism of estrogen response, an 
experimental and in silico approach are used. The expression levels of Notch1 and Notch 3 
were decreased treatment and the expression level of Notch 4 was increased upon estrogen 
treatment. In addition, bioinformatics analysis showed that, estrogen upregulates ERG family 
transcription factors, ELF family transcription factors, HOXL4 family transcription factors, 
KLF family transcription factors and transcription factor SOX3, which bind to Notch 1 
transcriptional regulatory region, implying indirect effects of estrogen on Notch 1 expression. 
Twenty biomaterials were also investigated in order to assess whether they provide an 
appropriate environment for MSCs expansion. It was found that eight of the biomaterials out 
of twenty designated as, CA-1, CA-2, CA-3, CI-K, CI-A, CIII-1, CIII-2 and CIII-3, were 
appropriate candidates to expand MSCs. The combination polymers designated as 
HPMA/PEG provided appropriate conditions when prepared in the proportion of 1:0 (CA-1), 
1:1 (CA-2) and 2:1 (CA-3). The appropriate proportion of polymers designated as 
HEMA/PEG/HPC was 2:1:1(CIII-1), 3:0:1 (CIII-2) and 1:1:0 (CIII-5).
Keywords: Mesenchymal Stem Cells, hypoxia, estrogen, notch receptors and biomaterials.
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ÖZET
ÇEVRESEL FAKTÖRLERİN MEZENKİMAL KÖK HÜCRE BİYOLOJİSİ 
ÜZERİNDEKİ ROLÜ
Sinan Gültekin
Moleküler Biyoloji ve Genetik Yüksek Lisans
Tez Yöneticisi: Doç. Dr. K. Can Akçalı
Ağustos 2009, 104 Sayfa
Mezenkimal Kök Hücreler (MKH) hem kendilerini yenileyebilmekte hem de yağ, 
kemik, kıkırdak ve kas hücrelerine farklılaşabilmektedirler. MKH’ların yenilenebilme ve 
farklılaşabilme özellikleri, içsel mekanizmaların yanısıra, fizyolojik dış faktörler tarafından da 
kontrol edilir. Buradan hareketle sıçan MKH modelinde, çevre faktörlerinin, MKH 
devamlılığındaki olası etkilerini belirlemek amaçlanmıştır.Farklılaşma, büyüme ve çoğalma 
kapasitesi üzerindeki etkisi göz önüne alınarak, hipoksi ve östrojenin, MKH’ler üzerindeki 
roller araştırıldı. MKH’lerin koloni oluşturma özelliklerinin hipoksik ortamda artığı ve bu 
artışın östrojenin eklenmesiyle daha da fazlalaştığı gözlemlendi. Buna ek olarak, östrojenin 
hipoksik ortamda, MKH’lerin apoptoza girmelerini engellediği gösterildi. Östrojenin Notch 
reseptör ifadesindeki etkisi hem deneysel,  hem de bioinformatik yöntemle araştırıldı. 
Deneysel olarak Notch1 ve Notch3 ekspresyonunun östrojenle birlikte azaldığı, ancak Notch4 
ifadesinin  arttığı gözlendi. Bununla birlikte, bioinformatik yöntemle östrojenin, ERG, ELF, 
HOXL4 transkripsiyon faktör aile gruplarının ve SOX3 transkripsiyon faktörü ifadesini
arttırdığı, bu transkripsiyon faktörlerinin Notch1’in transkripsiyonu regüle eden bölgelerine 
bağlandığı gösterildi. MKH’lerin büyümelerine uygun ortam oluşturmak için önceden 
hazırlanmış 20 tane biyomateryal kullanıldı, bunlardan sadece sekiz tanesi (CA-1,CA-2,CA-3, 
CI-A,CI-K,CIII-I,CIII-II ve CIII-2) MKH’lerin büyümesi ve gelişmesi için iyi bir ortam 
oluşturduğu saptanmıştır.   
Anahtar Kelimeler: Mezenkimal kök hücreler, hipoksia, östrojen, notch reseptör ailesi ve 
biomalzeme.
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11. INTRODUCTION
In the last century, the lifespan of humans has increased due to better life conditions. 
Advanced technology led to progressive research results for improved clinical applications 
and treatments. This longer life phenomenon has brought together the concept of a better life 
quality, since the body functions and health conditions decline with time. The recent research 
areas mainly focus on different intrinsic and extrinsic factors, which might help in the 
treatments of diseases and disorders which are results of a longer life time; such as cancer, 
osteoporosis, stroke and heart attack, in addition to neurodegenerative diseases like 
Parkinson’s disease.
Stem cells, which are an evolving research topic, have the ability for prolonged self-
renewal and differentiation into mature cells of various lineages, which make them important 
cell sources for therapeutic applications. Their remarkable ability to replenish and 
differentiate in vivo is regulated not only by intrinsic mechanisms but also by extrinsic 
physiological factors. These environmental factors are important for adult stem cell
maintenance. We plan to examine the effects of hypoxia and estrogen during this period. 
Hypoxia is one of the important environmental factors that plays role in the stem cell 
behavior. The niche structures where stem cells reside are quite hypoxic, and differentiation 
of stem cells is inhibited in hypoxic condition, while their “stemness” feature is maintained
(Poellinger and Lendahl 2008). It has been shown in other cells that one of the major 
pathways that participate in hypoxic response is notch pathway. Notch pathway also leads to 
differentiation of one type of stem or progenitor cells into their specific lineages, while 
prevent the differentiation of other stem/progenitor cells and keep them in a self renewal state. 
Estrogen is another important physiological factor and plays key role in development and 
maintenance of normal sexual and reproductive functions. It has also effect on the 
proliferation and migration of different stem cells. Use of biomaterials during the maintenance 
of cells is drawing interest in recent years since because they mimic the extra cellular matrix
(ECM) component (Tabata Y. 2009). Identification of new biomaterials has critical 
importance especially in stem cells since this recapitulates in vivo niche structures and allows 
manipulations in vitro. 
To elucidate the effects of hypoxia and estrogen, mesenchymal stem cells (MSCs) 
were examined at hypoxic condition in the presence of estrogen. Then, we investigated the 
effect of estrogen on notch expression in order to understand a possible mechanism. We used 
2both experimental and in silico approaches to shed light to its mechanism. Finally, use of 
appropriate biomaterials for MSCs’ expansion to mimic their niche structure was discussed.
1.1 Stem Cells
Stem cells are unspecialized cells which are capable of self-renewal and give rise to 
differentiated cells (Till and McCulloch. 1961). They are found in various sources such as the 
embryo, bone marrow, blood, cornea and retina of the eye, brain, skeletal muscle, dental pulp, 
liver, skin, lining of the gastrointestinal tract, and pancreas. Although self-renewal and 
differentiation to other cells are their common features; stem cells vary in their potential to 
differentiate, duration and pathways of self-renewal, places they are mostly found in, and 
division properties (Morrison et al. 1997).
Stem cells can be classified due to their source of origin and their potential to 
differentiate to different cell types. There are three main types of stem cells: Embryonic Stem 
Cells (ESCs), Germ Stem Cells (GSCs), and Adult Stem Cells (ASCs). In addition, a new 
type of stem cell- Induced Pluripotent Stem Cells (iPSs)  were identified in recent years  
generated by reprogramming of mouse embryonic fibroblast cells by inducing four defined 
factors ( Takashashi andYamanka. 2006).  
1.1.1 Embryonic Stem Cells
ESCs were first isolated from the inner cell mass of the mouse in 1981 by Kaufman 
and Martin, and from humans in 1998 by Thomson et al. ESCs are not embryos themselves 
but they can form cells from all three germ-layers and undergo an unlimited number of 
symmetrical divisions without differentiating in vitro (Burdon et al. 2002). In order to 
generate cultures of mouse and human ESCs, the inner cell mass is removed from the 
trophectoderm and is transferred to the top of mouse embryonic fibroblast (MEFs) cells on the 
culture medium. These MEFs which are called feeder layer are inactivated so that they cannot 
divide, but they provide a sticky surface for the ESCs to attach besides releasing essential 
factors to the culture medium. Both mouse ESCs and human ESCs can be grown both with 
and without a feeder layer (Xu et al. 2001). A single ESC can give rise to a colony of 
genetically identical cells, or clones under appropriate conditions (Sell. 2003)
ESCs can stay undifferentiated for a long period of time in vitro, and there are several 
examples to prove the pluripotentiality of ESCs. When mouse ESCs derived from one 
blastocyst are injected to another blastocyst and is transferred to the uterus of a 
pseudopregnant mouse in vivo, chimeras form which are a mixture of tissues and organs 
derived both from the host and the donor blastocyst (Prelle et al. 1999). Also when ESCs are 
3injected into adult immune-deficient mice, they develop into tumors called teratomas which 
contain cells from all three germ layers (Martin. 1981). In vitro when the culture conditions 
are changed, ESCs form embryoid bodies (EB) which have a similar structure to teratomas. 
They form large structures which contain partially differentiated cells from all three germ 
layers in a disorganized manner (Evans and Kaufman. 1981). Both mouse and human ESCs 
express oct-4 which is an important gene in the maintenance of pluripotency.
ESCs have high telomerase activity, which adds telomere repeats to the ends of 
chromosomes resulting in long telomeres (Armstrong et a., 2000) They have stable 
karyotypes, and X inactivation does not occur in the undifferentiated ESCs (Xu et al. 2001).
Unlike differentiated cells, ESCs do not require any external stimulus in order to initiate DNA 
replication. ESCs lack the G1 checkpoint in the cell cycle and spend most of their time in the 
S phase of the cell cycle synthesizing DNA. When they start to differentiate, the G1 phase of 
the cell cycle becomes longer with the increase in cyclin D expression and the rate of cell 
division slows (Burdon et al. 2002).  
ESCs can be used in several ways in basic and clinical research. Studies on ESCs are 
very informative on the complex events that occur during human development. Understanding 
the genetic and molecular control mechanisms behind the stem cell regulation may provide an 
understanding on how genetic and growth abnormalities arise and suggest new strategies and 
methods for their therapy. 
In addition to all the positive aspects of ESCs, there are several handicaps in their 
research and applications. Since there are many different cellular pathways regulating them, it 
is hard to figure out the interactions between them. ESCs cannot give rise to a full embryo but 
the fact that they are isolated from embryos creates problems, therefore there are ethical 
problems arising. In addition, when injected to immunodeficient mice, they form tumors. This 
indicates that due to their high differentiation potential, they can form any type of cell so they 
have to be controlled very strictly and all the factors affecting the differentiation of ESCs 
should be figured out before using them in any clinical application. Also ESCs have a 
potential to cause immune rejection, which is another obstacle. Until the big gaps are filled in 
the area of stem cell regulation and differentiation besides the ethical issues being solved, 
ESCs cannot be used in therapeutic applications.     
41.1.2 Embryonic Germ Cells
EGCs were first identified in 1998 by John Gearheart and they were cultured from 
primordial germ cells (PGCs) obtained from the gonadal ridge and mesentery of the 5th to 9th 
week of fetal tissue. They are pluripotent cells and express oct-4 besides other pluripotency 
markers similar to ESCs, and they have the capacity for long-term self-renewal. In addition 
they have a normal stable karyotype. The location and maintenance of germ-line stem cells 
are among the most studied areas and are clearly identified. Especially Drosophila is the best 
studied model in this area both in male and in female (Gilboa and Lehmann. 2004).   
PGCs are diploid germ cell precursors which transiently exist in the embryo before they 
are committed as germ cells. In order to obtain EGCs, PGC cultures are grown in fetal bovine 
serum supplemented media. The PGCs are plated on a feeder layer consisting of STO 
fibroblasts which are non-dividing. They are cultured in a growth medium which includes the 
cytokine, leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF), and 
forskolin. At the end of three weeks, the PGCs form dense, multilayered colonies of cells 
resembling EGCs. Although both are pluripotent, cultures derived from embryoid bodies 
generated from human EGCs have less capacity for proliferation compared to ESCs. EGCs 
will proliferate for 40 population doublings while human ESCs can proliferate for two years 
through 300 population doublings or even 450 population doublings (Pedersen. 1999). 
Another major difference between the pluripotency of ESC and EGC is that EGC do not form 
teratomas when injected to immunodeficient mouse (Pedersen. 1999). 
Although both are pluripotent, EGCs do not have the same proliferation and 
differentiation capacity as ESCs do, which makes EGCs less appealing for therapeutic 
applications. Also they do not form teratomas when injected to immunosuppressed mouse, 
and they do not participate in the formation of chimeras in vivo; which suggest that EGC’s 
differentiation potential is not as wide as ESC’s. In addition there is not much known about 
their telomerase activity either, which might be a reason why their doublings are shorter than 
ESCs (http://stemcells.nih.gov/).  
1.1.3 Induced Pluripotent Stem Cells
iPS cells are pluripotent cells that are derived from adult stem cells using 
reprogramming. In 2006, a group of Japanese scientists made pluripotent stem cells by 
introducing of Oct4, Sox2, Klf4, and c-Myc transcription factors into murine somatic cells 
(Takahashi and Yamanaka 2006). The first generation iPS cells were similar to ES cells in 
morphology, proliferation, the expression of some ES cell marker genes, and the formation of 
teratomas. However, these iPS cells had a different global gene expression pattern from ES 
5cells and failed to produce adult chimeric mice. In 2007, germline transmission was achieved 
with mouse iPS cells (Yamanaka 2007), and iPS cells were generated from human fibroblasts 
(Yamanaka 2009). Then four groups generated iPS cells from patients with various 
neurodegenerative diseases—amyotrophic lateral sclerosis (ALS), spinal muscular atrophy 
(SMA) and Parkinson’s disease and a variety of genetic diseases with either Mendelian or 
complex inheritance (Feng et al. 2009). In addition, iPS cells have been generated from both 
monkey and rat (Yamanaka 2009).
In addition, Thomson and colleagues were also able to reprogram human fibroblasts 
with a distinct set of transcription factors comprising OCT4, SOX2, NANOG, and LIN28 
(OSNL), indicating that KLF4 and c-MYC could be substituted with NANOG and LIN28 
(Feng et al. 2009). It was found that the orphan nuclear receptor, Esrrb, can replace Klf4 in 
the reprogramming of mouse embryonic fibroblasts (MEFs) when cotransduced with either 
OSM or OS (Feng et al. 2009). Besides transcription factors and epigenetic modifiers, micro-
RNAs may play an equally important role in reprogramming, commensurate with their 
emerging role in the maintenance of ESCs.  Only one particular microRNA, mir-302, which is 
expressed abundantly in human ESCs, has been implicated in reprogramming (Feng et al.
2009). In addition, several chemicals have recently been reported to either enhance 
reprogramming efficiencies or substitute for specific reprogramming factors. Among the 
reported chemicals, some are known to affect chromatin modifications, such as DNA 
methyltransferase inhibitor and histone deactylase inhibitors (Feng et al. 2009) 
iPS cell research does not raise any ethical problems since blastocysts or embryos are 
not destroyed. Therefore, it has opened the possibility of autologous regenerative medicine 
whereby patient-specific pluripotent cells could be derived from adult somatic cells 
(Yamanaka 2009) However, several limitations of most existing iPSCs prohibit their usage in 
the clinical setting.  First, virus-mediated delivery of reprogramming factors introduces 
unacceptable risks of permanent transgene integration into the genome. The resulting genomic 
alteration and possible reactivation of viral transgenes pose serious clinical concerns. Second, 
reprogramming factors Klf4 and c-Myc are oncogenic. Third, iPSC reprogramming is an 
inefficient and slow process. During the course of reprogramming, a substantial reduction in 
efficiency may also result from incomplete reprogramming (Feng et al. 2009). 
61.1.4 Adult Stem Cells
In the pioneering experiments with ASCs in 1940-1950’s, the researchers were able to 
repopulate the blood cells of a mouse by the infusion of bone marrow cells from a different 
mouse. In 1960; two different kinds of stem cell population have been identified in the bone 
marrow; hematopoietic stem cells (HSCs) which form all types of blood cells and bone 
marrow stromal cells which generate bone, cartilage, fat, and fibrous connective tissue. In the 
1990’s neural stem cells were discovered which are able to generate the brain's three major 
cell types: astrocytes, oligodendrocytes, and neurons.
ASCs are found in tissues and organs, and their primary role is to maintain 
homeostasis. They are important for the organ or tissue to fulfill their required task besides 
supplying them with the sufficient amount of stem cells for a life-time (Serakinci and Keith, 
2006). ASCs are mostly found in the bone marrow, blood, cornea and retina of the eye, brain, 
skeletal muscle, dental pulp, liver, skin, the lining of the gastrointestinal tract, and pancreas 
(Figure1.1). They usually divide to generate progenitor or precursor cells, which then give 
rise to specialized cells with specific shapes and functions (Weissman 2000). 
The number of ASCs is rare compared to other types of cells and they do not divide 
very often unless there is a stimulus such as tissue injuries or diseases. ASCs are scattered 
throughout the tissues of the mature organism and have very different roles depending on 
their local environment. Currently, cell surface markers and observations on stem cell 
differentiation patterns in test tubes and culture dishes are being used for the characterization
of adult stem cells. It is also hard to expand ASCs in culture in an undifferentiated state. Many 
factors including growth factors, extracellular matrix contacts, cell-cell interactions, and 
intrinsic cell kinetics (Sherley 2002) effect their maintenance and differentiation. 
Most of the ASCs are stored in specific cell compartments called niches, which are the 
microenvironments where ASCs are located with the same type of stem cells and 
differentiated cell types. These niches provide an extracellular matrix, adherens junctions, and 
integrins besides allowing physical interactions between cells. This enables stem cells to stay 
in an undifferentiated state and give rise to differentiated cell types when necessary. Niches 
are crucial by means of affecting the properties of stem cells but are not irreversible. They are 
also effective in the determination of symmetric division (Fuchs et al. 2004). In addition to 
differentiating into cells which they are programmed to, ASCs may also form the specialized 
cell types of other germlayers, which is known as plasticity (Horwitz 2003). If the 
mechanisms beneath adult stem cell plasticity can be identified and controlled, existing stem 
7cells from different sources might be used in the repair of diseased tissues and cells of other 
origins.  
Figure 1. 1: Adult Stem Cells (Raghunath J. et.al.2005)
The most commonly studied ASCs are HSCs, MSCs, neural stem cells, epithelial stem cells, 
and skin stem cells. HSCs give rise to red blood cells, B lymphocytes, T lymphocytes, natural 
killer cells, neutrophils, basophils, eosinophils, monocytes, macrophages, and platelets. MSCs 
give rise to osteocytes, chondrocytes, adipocytes, and other kinds of connective tissue cells 
such as those in tendons. Neural stem cells in the brain give rise to three major cell types: 
nerve cells (neurons) and two categories of non-neuronal cells: astrocytes and 
oligodendrocytes. Epithelial stem cells in the lining of the digestive tract give rise to 
absorptive cells, goblet cells, paneth cells, and enteroendocrine cells. Skin stem cells are 
found in the basal layer of the epidermis and at the base of hair follicles. They give rise to 
keratinocytes, hair follicle, and epidermis (http://stemcells.nih.gov/).
ASCs can be used in the generation of cells and tissues in cell-based therapies. The 
organs and tissues donated are often used to replace malfunctioning or destroyed tissues, but 
the need for transplantable tissues and organs is a lot more compared to the available supply. 
ASCs offer the possibility of a renewable source for replacement of cells and tissues to treat 
several diseases. ASCs are potential future treatments for various diseases such as cardiac 
disorders, diabetes, Alzheimer disease and many others (http://stemcells.nih.gov/).
8There are still many unknowns and questions to be answered such as how they stay 
undifferentiated in a differentiated environment, the signals regulating their differentiation 
and proliferation, the stimuli leading them to sites of injury, and how they can be increased in 
number in order to reach an adequate number to heal injuries. In addition, due to the large set 
of unknowns in this area, it is hard to identify, isolate, and maintain ASCs (Badge 2001). Also 
there are big gaps in the detection of the differentiation factors affecting their specialization, 
which prevent the in vitro tissue and organ synthesis. Mainly, the signals affecting ASC self-
renewal and differentiation should be revealed in order to consider ASCs for possible 
treatments.  
1.1.5 Mesenchymal Stem Cells
Adult MSCs were first discovered by Friedenstein et al., which were described as bone 
marrow-derived clonogenic, plastic-adherent cells capable of differentiating into osteoblasts, 
adipocytes, and chondrocytes. ( Friedenstein et. al. 1966). After that, different populations or 
subsets of bone marrow stromal cells were obtained. These other cells are referred to as bone 
marrow stromal stem cells (BMSSC) (Gronthos et. al. 2003), mesenchymal stem 
cells/marrow stromal cells (MSC) (Caplan 1994) marrow-isolated adult multipotent inducible 
cells (MIAMI) (D'Ippolito et. al. 2004), multipotent adult progenitor cells (MAPC), and 
mesenchymal adult stem cells (MASCS) (Belema-Bedada et. al. 2008). 
MSCs, in general, display significant heterogeneity. So far, there are no accepted 
specific surface markers for the isolation of MSCs. Instead, MSCs are defined retrospectively 
by a constellation of characteristics in vitro, including a combination of phenotypic markers 
and multipotent differentiation and functional properties (Liu et. al. 2009). 
The minimal requirement for a population of cells to qualify as MSCs is to meet the 
three criteria, including the plastic adherence of the isolated cells in culture, the expression of 
CD105, CD73, and CD90 in greater than 95% of the culture, and their lack of expression of 
markers including CD34, CD45, CD14 or CD11b, CD79 or CD19 and HLA-DR in greater 
than 95% of the culture, and the differentiation of the MSCs into bone, fat and cartilage 
(Dominici et. al. 2006).
Although MSCs and MSCs-like cells are isolated from the bone marrow, they are also 
located in other sites including adipose tissue, periosteum, synovial membrane, synovial fluid 
(SF), skeletal muscle, dermis, deciduous teeth, pericytes, trabecular bone, infrapatellar fat 
pad, articular cartilage, umbilical cord blood, placenta, liver, spleen, and thymus (Bianco et. 
al. 2008). Among the MSCs obtained from different sources, there is not much difference by 
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gene transduction capacity (Dominici et. al. 2006). 
MSCs are studied in various model organisms such as human, canine, rabbit, rat, and 
mouse and it is shown that MSCs isolated mostly from the bone marrow differentiate to 
different types of cells both in vitro and in vivo (Barry and Murphy 2004). The MSC isolation 
from every animal is from different sites of the bone marrow using different methods. In 
humans it is mostly from the pelvis (Digirolamo et al. 1999), tibia and femur. In larger 
animals it is from the same site but in rodents it is usually harvested from the mid-diaphysis of 
the tibia and femur (Barry and Murphy 2004). 
MSCs are a very small fraction of the nucleated cells in the bone marrow; only %0.01-
%0.1 of the total population (Pittenger et al. 1999). They can be isolated and expanded in 
tissue culture conditions with high efficiency and they can be induced to differentiate under 
specific conditions. They have fibroblastic morphology and they are adherent spindle-shaped 
cells. Under appropriate media conditions, MSCs adhere to the culture plate leading to the 
formation of colonies. Usually basal mediums with serum support are used to expend MSCs 
in tissue culture and growth factors are added in order for MSCs to differentiate (Barry and 
Murphy 2004) 
MSCs have a highly variable expansive potential in subculturing. Some MSC cultures 
can expand more than fifteen cell doublings, while others can replicate only about four cell 
doublings. There are several reasons for this difference such as the procedure to harvest the 
marrow, the low frequency of MSCs in marrow harvests, and the age or condition of the 
donor. Although MSCs have a high ex vivo expansion potential, they do not lose their normal 
karyotype and telomerase activity. However, in extensive subcultivation, signs of senescence 
and apoptosis are observed (Minguell et al. 2001). 
MSCs are characterized by their intrinsic self-renewal capacity, which is reflected in 
its clonogenic property and multi-lineage differentiation potential (Fig.1.2). Although not 
immortal, they have the ability to expand numerous times in culture while retaining their 
growth and pluripotent potential. In addition to their capacity to differentiate into 
chondrocytes, osteoblasts, and adipocytes, MSCs may serve as hematopoiesis-supporting 
stromal cells (Pittenger et. al. 1999). MSCs can differentiate into myocytes and 
cardiomyocytes and even into cells of non-mesodermal origin, including hepatocytes, insulin-
producing cells, and neurons (Jiang et. al. 2002). 
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Figure 1. 2  Pluripotent capacity of MSC to differentiate into mesodermal and non-mesodermal cell lineages, 
including osteocytes, adipocytes, chondrocytes, myocytes, fibroblasts, epithelial cells, and neurons  In addition, 
MSCs are capable to self-renewal. (Chen F et.al.2008)
The specific lineage commitment of MSCs is largely influenced by culture condition, 
especially growth factors. Growth factors that have regulatory effects on MSCs include 
members of the transforming growth factor-beta (TGF-b) superfamily, the insulin-like growth 
factors (IGF) , the fibroblast growth factors (FGF), the epidermal growth factor (EGF), the 
platelet-derived growth factor (PDGF), the vascular endothelial growth factor (VEGF), and 
the family of growth factors known as Wnt (Liu et al. 2009).
MSCs actively inhibit T-cell proliferation and due to this reason they are considered as 
nonimmunogenic or hypoimmunogenic which is important in host response to allogeneic 
MSC therapy (Uccelli et al. 2008). There are few mechanisms in immunospuression by 
MSCs. Contact-dependent mechanisms and soluble factors are thought to collaborate for the 
induction of MSC-mediated immunosupression. The interaction between MSCs and their 
target cells involves cell-cell contact mediated by adhesion molecules, such as PD1 and its 
ligands. Several soluble immunosuppressive factors have reported which either produced by 
MSCs or released following cross-talk with target cells, such as nitric oxide and indoleamine 
2,3- dioxygenase (IDO). 
Another important feature of MSCs is long-term homing and engraftment of 
implanted cells to various tissues even after the development of immunocompetence. The 
implanted MSCs can migrate to the specific site of injury by the help of factors that are 
released from the wound. This has been observed in cases like bone fractures, myocardial 
infarction, meniscus, and ischemic cerebral injury. Also at specific sites it has been observed 
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that the stem cells injected differentiate according to the local signals at the local site of injury 
(Miguell et al. 2001). MSCs have a high potential for regenerative medicine and tissue 
engineering besides being used as a gene delivery method, which makes their therapeutic 
value very high. Researchers are looking for different ways to use specialized cells derived 
from MSCs in targeting specific cancerous cells and delivering treatments that will destroy 
them or make them benign.
Besides these advantages of MSC in therapeutic applications, there are some 
unknowns like long-term effect and safety which require more toxicology studies. In addition, 
the efficiency is not clear. There are some evidences on homing and differentiation, but they 
are insufficient. Also large-scale culture, storage and distribution are important for their
applications of MSCs (Miguell et al. 2001).   
1.1.6 Stem Cell Niches
Stem cells unique ability to replenish themselves during the development, 
maintenance of tissue homeostasis, and repair of many tissues through self-renewal and 
differentiation are regulated by both intrinsic programming and input from their local 
environment, often referred to as the stem cell niche or microenvironment (Watt et. al. 2000).
Germ stem cells in the Drosophila ovariole and testis require physical interaction with 
supporting cap or hub cells, respectively, to retain stem cell identity. In the C. elegans gonad, 
the niche consists primarily of a single distal tip cell whose long cytoplasmic processes make 
extensive physical contact with germ stem cells (Keith et. al. 2007). 
In mammals, spatially defined stem cell niches have also been identified in multiple 
tissues, including the gonad, skin, intestine, and brain. A number of molecular factors that 
control stem cell identity have identified. These factors typically supplied by the supporting 
cells of the niche include components of the BMP, Notch, Wnt, JAK-STAT, and Sonic 
hedgehog (Shh) signaling pathways, which provide intercellular cues that regulate stem cell 
identity and differentiation (Keith et. al. 2007). 
In addition, niche structure provides mechanical stimuli and low oxygen tension. 
These features are shared by many types of adult stem cells. Indeed, increasing evidence 
demonstrates that oxygen tension is not only a metabolic substrate but also a powerful 
signaling molecule that regulates stem cell proliferation and differentiation (Ma et. al. 2009). 
Further information about effects of hypoxia on stem cell is discussed later. 
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1.2 Hypoxia
Oxygen is one of the essential elements that influence the evolution of life. Primitive 
life is considered to have started less than 4 billion years ago, and the first organisms that had 
the ability to convert and store the energy of light in the form of biochemical molecules with 
higher energetic potential appeared less than 3 billion years ago. The concentration of the 
oxygen started to increase in the atmosphere through the photosynthesis done by these 
organisms, during the next billion years. About 2 billion years ago, the concentration of O2 in 
atmosphere reached a level that influence life. Several adaptation mechanisms have been 
evolved by living organisms in order to detoxify the toxic effects of oxygen in parallel with 
the increase of O2 concentrations in atmosphere which continued until 500 million years ago 
(Ivanovic 2009).
Therefore, the eukaryotes, whose physiology based on the aerobic metabolism, are 
built during the evolution and became dependent on oxygen. Since inadequate oxygen 
availability can lead to cellular dysfunction and, since it causes cell death if its level is 
sufficiently profound in aerobic organisms, sophisticated systems are required to adjust the 
oxygen level, such as the cardiovascular system and the respiratory system (Kaelin and 
Ratcliffe 2008).
The blood circulation carries oxygen to tissues and a physiological tissue distribution 
of oxygen occurs as a result of progressive consumption of the oxygen in the blood circulation 
as it passes through different organs. The oxygen partial pressure (pO2) of inspired air is 
around 160 mmHg at sea level (Fig. 1.3). This drops progressively first in the lungs; in part 
due to water vapor and diffusion, then in the blood flowing from the alveolar capillaries that 
carry the oxygen, at a pO2 of around 104 mmHg, towards organs and tissues for their 
oxygenation. A further drop in the pO2 is observed in the venous system. The pO2 of a given 
tissue depends on the type of organ; rat spleen has a measured pO2 of around 16 mmHg, while 
the thymus was measured at 10 mmHg (Brahimi-Horn and Pouyssegur 2007). This “normal” 
tissue pO2 can be considered as “hypoxic” from a molecular standpoint. The low 
vascularization of the rat retina also makes it relatively hypoxic (2–25 mmHg) (Brahimi-Horn 
and Pouyssegur 2007), while tissues of the rat brain is even more hypoxic, 0.4–8.0 mmHg 
(Brahimi-Horn and Pouyssegur 2007). The diffusion distance of oxygen in a tissue is 
approximately 100–200 μm and an oxygen partial pressure of almost zero has been reported 
at only 100 μm from blood vessels (Brahimi-Horn and Pouyssegur 2007) 
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Figure 1. 3 Physiological and pathophysiological oxygen partial pressures (pO2). The pO2 of inspired air drops 
progressively as oxygen passes from the lungs into the circulation, which irrigates the tissues of major organs, 
and then in the venous system before re-oxygenation in the lungs. (Brahmi et al. (2009)). 
In mammals an increase in altitude results in an initial physiological response that 
increases the rate and depth of breathing. Low levels of oxygen in tissues (hypoxia) also arise 
in normal development and as a consequence of a number of pathophysiological conditions 
where there is a diminished oxygen supply due to a defective vasculature. Such conditions 
include ischemic disorders (cerebral or cardiovascular), diabetes, atherosclerosis, 
inflammatory diseases, psoriasis, pre-eclampsia, chronic obstructive pulmonary disease and 
cancer (Brahimi-Horn and Pouyssegur 2007). 
In these responses, at the molecular level, cells have ability to sense the oxygen 
availability whether it is insufficient, and thus undergo adaptive changes in gene expression 
that either enhance oxygen delivery or promote survival in a low oxygen (hypoxic) 
environment. An evolutionarily conserved pathway mediated by oxygen-dependent 
posttranslational hydroxylation of a transcription factor called hypoxia-inducible factor (HIF) 
plays a pivotal role in this process (Kaelin and Ratcliffe 2008).
There are three isoforms of hypoxia inducible factors. All three factors bind to a 
hypoxia response element (HRE; 5’-RCGTG-3’) found in the target genes. (Semenza et. al., 
1991). HIF-1 belongs to the basic helix-loop-helix Per-ARNT-Sim (bHLH–PAS) protein 
family (Fig. 1.4) (Wang et. al. 1995), where it composes, in hypoxic condition, a 
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heterodimeric complex with HIF-1which is also known as the aryl hydrocarbon nuclear 
translocator (ARNT). 
HIF-2is a closely related protein to HIF1-and is also termedendothelial PAS 
protein, HIF-like factor (HLF), HIF-related factor (HRF), and member of the PAS 
superfamily 2 (MOP2) (Tian et. al. 1997). 48% amino acid sequence identity of HIF-2is 
similar to HIF-1It also share structural and biochemical similarities with HIF-1, such as 
heterodimerization with HIF-1 and binding HREs. Although HIF- 1is ubiquitously 
expressed, expression of HIF-2is tissue specific such as in the lung, endothelium, and 
carotid body (Ke and Costa 2006). 
HIF-3 is the latest discovered isoform between hypoxia inducible factors. This 
transcription factor is also expressed in a different tissues and can dimerize with HIF-1 and 
binds to HREs. HIF-3has splice variant, inhibitory PAS (IPAS), which is predominantly 
expressed in the Purkinje cells of the cerebellum and corneal epithelium. IPAS possesses no 
endogenous transactivation activity. Instead, it interacts with the amino-terminal region of 
HIF-1 and prevents its DNA binding, acting as a dominant negative regulator of HIF-1. (Ke 
and Costa 2006)
The bHLH and PAS motifs are required for heterodimer formation between the HIF-
1 and HIF-1 subunits, and the downstream basic regions required for specific binding to 
the HRE DNA sequence (Crews 1998). HIF-1has two transactivation domains, called N-
terminal (N-TAD) and C-terminal (C-TAD), in the C-terminal half of the HIF-1 protein 
(Ruas et. al. 2002). The C-TAD interacts with coactivators such as CBP/p300 to activate gene 
transcription (Lando et. al. 2002).  HIF-1_ also contains an oxygen-dependent degradation 
domain (ODDD) that mediates oxygen-regulated stability (Pugh et. al. 1997).
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Figure 1. 4 Domain structures of human HIF- and HIF-1. HIF- ( HIF-1, HIF-2, HIF-3 IPAS) and HIF-
belong to the bHLH and PAS protein family.  HIF- contains an ODDD that mediates oxygen-regulated 
stability through the hydroxylation of two proline (P) residues and the acetylation of a lysine (K). HIF-1 and 
HIF-2 also contain two transaction domains (C-TAD and N-TAD), whereas HIF-1 has only one TAD (KE 
et.al. (2006). 
Despite of the fact that HIF-1 beta protein is constitutively expressed and its mRNA 
and protein level are constant regardless of oxygen availability, HIF-1 alpha protein is highly 
controlled by oxygen (Salceda and Caro 1997). In normoxia, HIFα becomes hydroxylated at 
one (or both) of two highly conserved prolyl residues located near the NTAD by prolyl 
hydroxylase domain (PHD) family (Kaelin 2005). In normoxia, hydroxylation of two proline 
residues and acetylation of a lysine residue in its ODDD promote interaction of HIF-1 with 
the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex, which is a component of a 
ubiquitin ligase complex (Masson et. al. 2001).  As a result, HIFα is polyubiquitylated and 
subjected to proteasomal degradation by 26S proteasome when oxygen is available. 
The PHD proteins belong to the Fe(II) and 2-oxoglutarate-dependent oxygenase 
superfamily, whose activity is dependent on oxygen. Under low oxygen conditions, HIFα 
accumulates then dimerizes with an HIFβ family member, translocates to the nucleus, and 
transcriptionally activates 100–200 genes, including genes involved in erythropoiesis, 
angiogenesis, autophagy, and energy metabolism (Kaelin and Ratcliffe 2008)
FIH1, like the PHD family members, is an Fe(II)- and 2-oxoglutarate-dependent 
dioxygenase. When oxygen is available, FIH1 hydroxylates a conserved asparaginyl residue 
within the HIF1α and HIF2α CTADs, and thus prevents the recruitment of the coactivators 
p300 and CBP (Kaelin and Ratcliffe 2008). FIH1 remains active at lower oxygen 
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concentrations than the PHDs and so might suppress the activity of HIFα proteins that escape 
destruction in moderate hypoxia (Dayan et. al. 2006).
Moreover, HIF-1 is acetylated by an acetyltransferase named arrest-defective-1 
(ARD1) at Lysine residue located in the ODDD domain, which favors the interaction of HIF-
1 with pVHL, and thus destabilizes HIF-1 (Jeong et. al. 2002).  
Despite the central importance of hydroxylases in sensing oxygen tension and 
regulating HIF-1 activity, there are other mechanisms that contribute to the control of HIF-1. 
Phosphorylation is well known to be crucial in controlling protein activities. Direct
phosphorylation of HIF-1 has been reported, and the mitogen-activated protein kinase 
(MAPK) pathway seems to play a role (Minet et. al. 2001). Phosphorylation does not affect 
stability or DNA binding of HIF-1; instead, it increases the transcriptional activity of HIF-1. 
In addition to the post-translational modification of HIF-1 , SUMOylation of HIF-1
contributes to repressing transactivation (Brahimi-Horn et. al. 2005). 
HIF-1 is also regulated in an oxygen-independent manner. Cytokines, growth factors, 
environmental stimuli, and other signaling molecules have been implicated in controlling HIF-
1 under non-hypoxic condition. Although complex and cell-type dependent, some stimulate 
HIF-1 transactivation or synthesis by activation of the MAPK or the phosphatidylinositol 3-
kinase (PI3K) signaling pathways (Ke and Costa 2006).
The PHDs and FIH1, like other 2-oxoglutarate-dependent oxygenases, employ a two-
histidine-one-carboxylate facial triad to coordinate the catalytic Fe(II) center, leaving two 
positions for binding 2-oxoglutarate, and one for molecular oxygen. During catalysis, the 
splitting of molecular oxygen is coupled to the hydroxylation of HIFα and to the oxidative 
decarboxylation of 2-oxoglutarate to succinate and CO2. The reaction proceeds via the 
formation of a highly reactive ferryl (FeIV = O) intermediate that oxidizes the target amino 
acid residue. Ascorbate is required for full catalytic activity and likely functions to reduce the 
catalytic iron in the event of uncoupled turnover, in which failure to oxidize the HIFα 
substrate leaves the iron center in an oxidized and inactive form (Schofield and Ratcliffe, 
2004). Therefore, The HIF hydroxylases are also inhibited in vivo by iron chelators (Page et. 
al. 2007). 
1.2.1 Hypoxia and Stem Cells
The effect of oxygen tension on stem cell physiology has been studied for over 30 
years (Toya et. al.,1976). For hematopoietic stem cells (HSCs), it has been found that 
cultivation under low oxygen tensions maintained a significantly higher number of long-term 
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colony initiating cells (LTC-ICs) relative to cultures under ambient (20%, v/v) oxygen 
concentrations.(Cipolleschi et. al. 2000). Recently, it has also been observed, in several other 
stem and progenitor cell populations, that cultivation under hypoxic conditions resulted in 
enhanced proliferation and maintenance of their naïve states (Csete et. al. 2006). In vivo
studies have shown that mesenchymal stem and progenitor cells home specifically to hypoxic 
niches (Ma et. al. 2009). Although the identity of cellular oxygen sensor is being debated, 
emerging evidence indicate that some of the effects of hypoxia on stem cell function are 
directly regulated by hypoxia-inducible factor (HIF) proteins (Keith et. al. 2007). 
1.2.2 Bone Marrow Microenvironment
The oxygen distribution within the bone marrow has been studied almost exclusively 
in the context of hematopoietic stem cells (HSCs) and to a much lesser extent in the context of 
MSCs. However, bone marrow has a hierarchical structure, in which the haematopoietic 
compartments are bound by stromal elements (Weiss et. al. 1976) - mainly mesenchymal stem 
cells (MSCs) - and such that the two cell types form an integral part of each other's niche 
(Figure 1.5).  It has long been proposed that hematopoietic progenitors exist at high 
concentration at the endosteal surface and release via the central venous sinus as they 
differentiate and mature (Lord et. al. 1990). Early direct measurement revealed that bone 
marrow in general is hypoxic, where some regions are as low as 1-2% O2 (Ma et. al. 2009).  
Figure 1. 5. Oxygen tension in bone marrow is well below ambient oxygen environment in the range of 3–7% 
O2 with oxygen concentrations decreasing with distance away from sinuses. (Ma T. et.al. 2008)
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1.2.2.1. Effects of Hypoxia on Haematopoietic and Embryonic Stem Cells 
Embryonic stem (ES) cells grow more efficiently under low O2 conditions, as opposed 
to in ambient air that is supplemented with 5% carbon dioxide. It was previously noted that 
bovine blastocysts produced under reduced O2 tensions exhibited significantly more inner cell 
mass (ICM) cells than those that were maintained at higher O2 levels(Simon M. C. and Keith 
B. 2008). The ICM and its ES cell counterparts are pluripotent. Roberts et al.demonstrated 
that human ES cells proliferate at a similar rate when cultured at 3–5% O2 as they do under 
21% O2. The authors concluded that hypoxic conditions are required to maintain the full 
pluripotency of mammalian ES cells (Simon M. C. and Keith B. 2008). HSCs and their 
proliferating progenitors are naturally occupying the most hypoxic niches. Furthermore, 
Danet et al. demonstrated that culturing bone marrow HSCs at 1.5% O2 promoted their ability 
to engraft and repopulate the haematopoietic organ of immunocompromised recipient mice 
(Simon M. C. and Keith B. 2008)
1.2.2.2. Effects of Hypoxia on Bone Marrow-Derived Mesenchymal Stem 
Cells
In general, MSCs exhibited greater colony-forming potential, proliferated faster, and 
longer, and maintained their undifferentiated characteristics better under low oxygen 
conditions (Ma et. al. 2009). It has been shown that hMSCs grown in 3D scaffolds under 
extended hypoxic conditions (2% O2) increased their expression of pluripotent genes Oct-4 
and Rex-1 and had elevated CFU-F ability while maintaining their ability to differentiate 
along osteogenic or adipogenic lineages (Grayson et. al. 2006). In two-dimensional (2D) 
culture studies, hMSCs under hypoxic conditions exhibited 30-fold greater expansion 
potential over a 6-week period than normoxic cells, homogenously maintained their spindle 
morphology, and formed multiple cell-layers with high expression of connexin-43 (Grayson 
et. al. 2007). Hypoxia affects the differentiation characteristics of MSCs in ways that may be 
correlated with the physiological oxygen requirements of the differentiated cells (Fink et. al.
2004).
1.2.3 The role of HIFs in regulating stem cells
Some of the effects of hypoxia on stem cell function are directly mediated by the HIF 
proteins. Targeted mutation of the ARNT subunit eliminates both HIF-1α and HIF-2α 
function and results in a decreased number of progenitor cells of all hematopoietic lineages in 
the embryonic yolk sac of Arnt−/− mouse embryos (Keith et. al. 2007). 
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Recently, new molecular mechanisms by which HIFs directly modify cellular 
differentiation and stem cell function have been defined. Lendahl, Poellinger, and colleagues 
reported that hypoxia blocked the differentiation of myogenic satellite cells, a myogenic cell 
line (C2C12), and primary neural stem cells in a Notch-dependent manner (Gustafsson et. al.
2005).  It was shown that HIF-1α was physically recruited to a DNA-binding complex 
containing the Notch intracellular domain in hypoxic cells. Hypoxic induction of Notch target 
genes was dependent on the Notch intracellular domain and also required the functional C-
terminal transactivation domain of HIF-1α, which interacts directly with p300/CBP. 
The links between the HIFs, Notch, and Oct4 reveal specific molecular mechanisms 
whereby oxygen responses can inhibit differentiation and, possibly, promote stem cell 
identity. They also raise the possibility of crosstalk between hypoxia and other stem cell 
signaling pathways.  TGF-β has been reported to induce HIF-α stabilization by inhibiting 
PHD2 (McMahon et. al. 2006). In addition, a recent paper describing physical interaction 
between β-catenin and HIF-1α suggests at least one mechanism by which Wnt signaling 
might affect HIF activity in stem cells (Kaidi et. al. 2007). 
1.3 Estrogen 
Estrogen is a hormone which is produced by the ovaries and testes. It stimulates the 
development of secondary sexual characteristics, induces menstruation, and regulates growth, 
differentiation, cell proliferation, metabolic activities, reproduction, homeostasis, 
cardiovascular health, bone integrity, cognition, and behavior. It targets many organs like the 
brain, heart, bone, breast, uterus, and prostate. This wide range of organs, which estrogen is 
involved in the functioning of, makes estrogen a very important hormone for therapy and 
therefore it is crucial to understand the imbalances of estrogen, gene networks controlled by 
estrogen, and regulation of its targets (Deroo and Korach 2006). 
Estrogen controls the expression of a wide variety of genes through distinct genomic 
and nongenomic pathways. In the classical genomic pathway, estrogen signals are mediated 
through the estrogen receptor (ER), which functions as a transcription factor for target genes. 
In the nongenomic pathway, estrogen regulates the functions of factors in cells through 
various mechanisms, including protein phosphorylation (Norman et. al. 2004). 
20
1.3.1 Estrogen Signals 
1.3.1.1. Ligand-Dependent Genomic Pathways
Estrogen exerts its biological effects by binding to ER, which mainly exists in the 
nucleus as a member of the nuclear receptor superfamily of transcription factors (Figure 1.6). 
ER acts through the formation of homo- or heterodimers of ERα and ERβ. In the classical 
pathway, estrogen-bound ERs dimerize and function as a transcription factor which binds to a 
specific DNA sequence named the estrogen response element (ERE) present in the promoter 
or enhancer regions of target genes. ER binds to ERE through its DNA-binding domain 
(DBD) and recruits coactivators such as SRC-1, AIB1 and p300/CBP to form a functional ER 
complex. It is now known that ER target genes which have full or half ERE sites (Smith et. al.
2004). 
In the genomic pathway, ER can also regulate transcription without binding directly to 
DNA. ER acts as a coactivator, and interacts with other transcription factors such as AP-1, 
SP-1 and NF-κB via protein–protein interactions, and it could regulate the transcription of 
genes that lack ERE but has a binding element for its partner’s protein (Hayashi et. al. 2009).
1.3.1.2. Nongenomic Pathways
Estrogen also exerts its effects that are not accounted for by transcriptional 
mechanisms (Figure 1.6). There is accumulating evidence that estrogen receptors are also 
located at the plasma membrane and are responsible for nongenomic actions (Hayashi et. al.
2008) Membrane ER associates with many growth factor receptors, such as IGF-1R, EGFR, 
HER2. In the activation of IGF-1R, E2 induces the formation of a ternary complex among 
ERα, IGF1-R and Shc, the adaptor protein, in the plasma membrane, which induces 
phosphorylation of IGF-1R (Song et. al. 2004). The estrogen-bounded membrane ER 
activates several signals in a cell type-specific manner, including calcium currents, cAMP, 
inositol phosphate, G proteins, Src, and Shc, which leads to the activation of downstream 
kinases, such as mitogen-activated protein kianse (MAPK) and phosphatidylinositol 3-kinase 
(PI3K)/Akt (Norman et. al. 2004). 
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Figure 1. 6: Outline of estrogen signaling pathways. Estrogen evokes genomic and nongenomic actions via 
nuclear ER and membrane-associated ER. Moreover, these signals are also stimulated or modulated by crosstalk 
with the intracellular protein kinase-mediated phosphorylation signaling cascade (Hayashi S. et.al 2008).
1.3.2 Estrogen and Hypoxia
The relationship between hypoxia and estrogen-mediated pathways comes from breast 
cancer. It has been shown that, in T47 human breast cancer cells, the expression level of 31 
genes out of 8000 changes in hypoxic condition increase in the presence of estrogen. These 
genes are involved in cell growth, differentiation, angiogenesis, protein transport, metabolism, 
and apoptosis (Yi. et. al. 2009). 
So far, there have been two possible mechanistic explanations for the relationship 
between estrogen and hypoxia. One mechanism is that HIF-1α is a coactivator for ERα itself. 
Other is that HIF-1α activates intermediary cofactors for ERα that further facilitate ERα 
transactivation (Fig. 1.7), such cofactors as SRC, CBP, ASC (Seifeddine et. al., 2007).  In 
addition, HIF-1α directly controls ERs activation and degradation, where the level of ERα 
decreases in hypoxia.  The mechanisms of ERa downregulation during hypoxia are probably 
dependent on both increased proteasomal degradation of ERa and decreased transcriptional 
ERa-activation. The transcriptional inhibition of ERa during hypoxia seems to be mediated by 
the ERK pathway (Kronblad et. al. 2005).
However, there is no interplay between ERβ and HIF-1α in contrast to ERα. It was 
shown that estrogen-occupied ERα activates HIF-1α by the MAPK and PI3K pathways in the 
uterus (Kazi and Koos 2007). Even if mechanism is not known HIF-1α is a coactivator only 
for ERα, but not ERβ.  HIF-1 α mediated ERα activation involves the C-terminal domain of 
estrogen in which C-terminal AF-2 is found, and is important for the transcription activation. 
Some coregulators, such as SRC-1, TIF-2, and AIB-1, interact with the AF-2 of ERα, whereas 
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other cofactors, such as p68 RNA helicase protein, interact with AF-1 in potentiating ERα 
function (Yi.et. al. 2009)
Figure 1. 7: A proposed model of the effects of E2 and hypoxia on transactivation of ERs. Unknown factor(s) 
recruited by HIF1α specifically interact(s) with ERα and synergistically activate(s) transactivation of ERα (A). 
Such synergism is not observed with ERβ (B) (Yi et. al. 2009).
1.3.3 Estrogen and Notch 
There are no direct results showing the relationship between Notch pathway and 
estrogen. The direct link between Notch signaling pathway and estrogen comes from breast 
cancer. It has been shown that the amount of Notch-1 was increased by 17β-estradiol 
treatment in breast cancer cell lines such as T47D or MCF-7 (Rizzo et. al. 2008). Rizzo et. al. 
(2009) showed that loss of estrogen signaling caused Notch re-activation because Notch-1 is 
found primarily on cell surface and nuclear levels NIC are reduced when cells are treated with 
estrogen, suggesting that cross-talk between estrogen and Notch signaling leads to Notch re-
activation.
1.3.4 Estrogen and Stem Cells
Gender differences, by the differential effects of sex-specific hormones, exist in a 
variety of cardiovascular, cardiopulmonary, neurodegenerative, endocrine and metabolic bone 
diseases such as osteoporosis (Figure 1.8). Recent studies reported the presence of estrogen
receptor on stem cells, suggesting that estrogen may modify the function of those cells (Ray 
R. et. al. 2008). 17β-estradiol enhances the proliferation and migrations of some stem cells, 
such as endothelial progenitor cells (EPCs), to the injured vessels, or ischemic myocardial 
tissues through the process of homing and help in repair and regeneration to compensate for 
the lost tissue. Thus, modification of the function of stem cells through estrogenic stimulus 
may increase the function of stem cells (Ray R et. al. 2008). 
23
Figure 1. 8: Effects of estrogen on various stem cells and progenitor cells. ESC (embryonic stem cell); EPC 
(endothelial progenitor cell); MSC (mesenchymal stem cell); HSC (hematopoietic stem cell); CF (cardiac 
fibroblast); BMP (bone matrix protein); RUNX2/ CBFA1 (runt-related transcription factor 2/core-binding factor 
alpha) (Ray R. et.al.2008)
Estrogens may enhance the protective function of MSCs by increasing or decreasing 
cytokine and growth factor production (Crisostomo et. al.2008). Female MSCs express less 
amount of proinflammatory cytokines, TNF-α and IL-6, when compared with male MSCs in 
inflammatory reactions (Crisostomo et. al. 2006).   
Furthermore, estrogen plays a role in osteogenic differentiation of MSCs through the 
ERα receptor, and support growth and differentiation (Wang et. al. 2006). When bone marrow 
MSCs are subjected to osteogenic differentiation medium supplemented with 17β-estradiol, 
the expression levels of bone morphogenetic protein (BMP) and osteocalsin increase together 
with increase calcium deposition (Hong et. al. 2006). 17β-estradiol also stimulates the 
expression of osteogenic genes for ALP, collagen I, and TGF-β1 in MSCs. 
1.4 Notch Signaling Pathway
Notch signaling has been shown to regulate a broad range of events during embryonic 
and post-natal development, including proliferation, apoptosis, border formation, and cell fate 
decisions. In self-renewing organs in vertebrates, inhibition of differentiation, lineage 
specification at developmental branch points and induction of differentiation are relevant 
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functions of Notch signaling (Artavanis-Tsakonas et. al. 1999).  In addition, Notch signaling 
plays a role in stem cell maintenance (Rajan et. al. 2009). 
Both Notch receptor and its ligands, Delta and Serrate (known as Jagged in 
mammals), are transmembrane proteins with large extracellular domains that consist primarily 
of epidermal growth factor (EGF)-like repeats (Figure 1.10).  There are four Notch receptors 
in mammals: (Notch1–4), two in Caenorhabditis elegans (LIN-12 and GLP-1) and one in 
Drosophila melanogaster (Notch).
Ligand binding promotes two proteolytic cleavage events in the Notch receptor (Fig. 
1.9). The first cleavage is catalysed by ADAM-family metalloproteases, whereas the second is 
mediated by γ-secretase, an enzyme complex that contains presenilin, nicastrin, PEN2 and 
APH1 (Fortini 2002). The second cleavage releases the Notch intracellular domain (Nicd), 
which then translocates to the nucleus and cooperates with the DNA-binding protein CSL 
(named after CBF1, Su(H) and LAG-1) and its coactivator Mastermind (Mam) to promote 
transcription (Fortini 2009).
Notch signaling is important for ‘lateral inhibition, a transcriptional feedback 
mechanism that explains how Notch signaling can drive two initially identical progenitor cells 
to adopt different fates (Fortini 2009).
Initially, the two interacting cells are equivalent, each expressing comparable levels of 
the Notch receptor and DSL ligands, and thus possessing equivalent signal-sending and 
signal-receiving activities. Over time, a small difference in some aspect of signaling arises 
between the two cells. This initial difference is amplified by a transcriptional feedback loop 
wherein Notch signaling activates transcription of the Enhancer of split gene family, which 
encodes bHLH transcription factors that in turn repress target genes (Fortini 2009).
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Figure 1. 9: DSL ligands and Notch receptors: (a) Notch ligands are transmembrane proteins that are 
characterized by an N-terminal DSL (Delta, Serrate and LAG-2) domain that is essential for interactions with the 
Notch receptor. The extracellular domains of the ligands contain varying numbers of epidermal growth factor 
(EGF)-repeats. The ligands are subdivided into two classes, Delta or Delta-like (Dll) and Serrate (Jagged in 
mammals), depending on the presence or absence of a cysteine rich (CR) domain. (b) Notch extracellular 
domains contain 29–36 EGF repeats, 3 cysteine rich LIN repeats and a region that links to the transmembrane 
and intracellular fragment. This linker region is important in preventing premature activation of the receptor. 
EGF-repeats 11 and 12 are essential for ligand binding. The intracellular portion consists of a RAM domain, six 
ankyrin (Ank) repeats and a C-terminal PEST domain. It also contains nuclear localization signals. Individual 
types of Notch receptor have additional protein–protein interaction motifs. (Bray 2006)
Figure 1. 10 Schematic illustration of Notch and the pathway.  (1) Secretory pathway: Notch is translated inside 
ER, where it is glycosylated by an O-fucosyltransferase O-Fut1 and O-glucosyltransferase Rumi. Notch is then 
translocated into Golgi, where it is cleaved by Furin protease at the S1 site and further modified by the N-
acetylglucosaminyltransferase, Fringe. (2) Ligand-mediated activation: Notch interacts with the DSL ligands, 
Delta and Serrate, resulting in a series of proteolytic cleavage events induced by ligand binding. The S2 cleavage 
is mediated by ADAM protease, whereas the S3/4 cleavage event is mediated by -secretase. (3) The endocytic 
regulation of the Notch receptor: Full-length Notch can undergo endocytosis, leading to translocation of Notch 
into EEs, MVB, and lysosomes (Kopan R. et.al 2009).
26
1.4.1 CSL proteins
CSL proteins are the essential effectors of the Notch pathway. Nicd forms a trimeric 
complex with CSL and the co-activator Mam, which is essential for Nicd-dependent 
transcription (Nam et. al. 2006). Another Nicd-interacting protein, SKIP (Ski-interacting
protein), a transcriptional coregulator and component of spliceosomes, is also recruited to 
promoters at the same time (Fryer et. al. 2004). Mam in turn recruits the histone acetylase 
p300, which promotes assembly of initiation and elongation complexes (Bray 2006).
The assembly of the co-activator complex not only promotes transcription, but also 
results in turnover of Nicd, which is achieved by recruitment of cyclin-dependent kinase-8 
(CDK8), which phosphorylates Nicd, rendering it into a substrate for the nuclear ubiquitin 
ligase SEL10 (Fryer et. al. 2004). Destruction of Nicd would result in the dissociation of 
Mam and other co-activator.  
1.4.2 Epigenetic regulators
In the absence of Notch activity, CSL proteins remain on the DNA and recruit co-
repressors. In D. melanogaster, the adaptor Hairless tethers the more global repressors 
Groucho and CtBP, which recruit histone deacetylases (Nagel et. al. 2005). In mammalian 
cells, co-repressors interact with CSL, including SMRT (also known as NcoR) and SHARP 
(also known as MINT/ SPEN), which in turn recruit CtBP or other global co-repressor 
(Oswald et. al., 2005). However, number cofactors interact with CSL, including the histone 
acetyl transferase GCN5 and the SWI/SNF chromatin-remodelling enzyme Brahma (also 
known as BRM) (Bray 2006).
1.4.3 Notch Signaling Pathway and Stem Cells
A diversity of stem cell subsets require Notch signaling for the productive 
maintenance of tissues.  In skeletal muscle, expression of the Notch ligand Delta is essential 
for activation of endogenous stem cells (satellite cells) after injury (Conboy et. al. 2003)
Likewise, Notch plays a key role in the self renewal of intestinal and hematopoietic 
stem cells, and is required during various stages of stem cell commitment to lineage 
specification. Interestingly, Notch is likely to operate in other less well-defined systems, such 
as in osteogenesis (Carlson and Conboy 2007).  
The function of endogenous Notch signaling in mammalian ESCs is just beginning to 
be understood in detail. mRNAs encoding Notch1–3 and DLL1 are present at high levels in 
hESCs. Conversely, Notch2 is expressed at much lower levels. Notch signaling is thought to 
be relatively inactive in undifferentiated hESCs (Rho et. al. 2006).
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However, Notch might not be a required signaling component for ESC self-renewal, 
rather, Notch is likely to be involved during specific differentiation intervals of ESCs. For 
example, it could play a role in regulating the decisions between mesodermal and 
neuroectodermal cell-fates. Neural specification of ESCs is influenced by Notch signaling, as 
Notch1 activation promotes neural lineages and suppresses ESC differentiation into 
mesodermal cell fates (Noggle et. al. 2006).
The mammalian intestinal epithelium has one of the highest turnover rates in the body 
and comprises stem cells, transit amplifying (TA) cells and terminally differentiated cells. 
One function of Notch signaling within the small intestine is to maintain proliferative crypt 
progenitors in the undifferentiated state, while a second function is to influence a binary cell 
fate decision of TA cells that have to choose between the adsorptive and the secretory 
lineages such as goblet cells and enteroendocrine cells. This process seems to be regulated by 
the Notch target gene Hes1, which transcriptionally represses Math1. Math1 is required for 
the development of secretory lineages while Hes1 expression favors the development of 
adsorptive cells (Wilsona and Radtke 2006).
In fetal hematopoiesis, Notch1 signaling is necessary for developing stem cells within 
the AGM (aorta-gonad-mesonephros) region. In adult BM (bone marrow) progenitors Notch 
signaling inhibits differentiation of stem cells (HSCs). Downregulation of Notch1 signaling is 
required in BM B cell progenitors to allow normal B cell development. In the thymus Notch1 
signaling is essential for T lineage specification in an early thymocyte progenitor, while at 
subsequent developmental stages it promotes differentiation of pro-T cells into pre-T cells of 
the αβT lineage (Wilsona and Radtke 2006).
In the skin, Notch1 signaling induces expression of early differentiation markers such 
as Keratin1 and Involucrin, and partially represses the expression of Loricrin and Filagrin, 
two late differentiation markers. Moreover Notch1 induces expression of the cell cycle 
regulator p21CIP1/WAF by two mechanisms. First, Notch1 targets the p21CIP1/WAF promoter 
directly, and second Notch1 upregulates p21CIP1/WAF through the activation of 
calcineurin/NFAT activity mediated by the downregulation of calcipressin via the Notch 
target gene Hes1. Both Wnt- and Shh-mediated signaling are normally repressed in the 
murine epidermis by Notch1. Repression of the Wnt pathway is at least partially mediated by 
the downregulation of Wnt4 through a p21CIP1/WAF:E2F-1-dependent mechanism (Wilsona and 
Radtke 2006).
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1.4.4 Notch Pathway and Hypoxia in Stem Cells
Notch signaling and the cellular hypoxic response synergize at various levels in the 
pathways (Figure 1.11). A link between Notch and hypoxia was first suggested by that the 
Notch target gene Hes1 was upregulated by hypoxia in neuroblastoma cell lines. It has also 
been shown that hypoxic response requires functional Notch signaling, demonstrated for 
myogenic and neural stem cell differentiation and more recently for hypoxia-induced 
epithelial-to-mesenchymal transition in tumor cells (Poellinger and Lendahl 2008).
At the molecular level, there are a number of interaction points between the Notch and 
hypoxia pathways, and various potential transcriptional outcomes of this cross-talk are 
outlined in Figure 6. HIF-1α is recruited to a DNA-binding complex containing the Notch 
intracellular domain in hypoxic cells. Hypoxic induction of Notch target genes is dependent 
on the Notch intracellular domain and also required the functional C-terminal transactivation 
domain of HIF-1α, which interacts directly with p300/CBP (Keith  and Simon  2007). 
It is not clear how hypoxia affects the activation of Notch-responsive, but it is 
speculated that there is a cell-context-dependent transcriptional response because the 
activation of Hes and Hey genes are observed in different cell types (Poellinger and Lendahl 
2008).  Some genes, such as Hey 1, Hey 2, and Dll4, contain both HRE-binding and CSL-
binding sites, and hypoxia and Notch may therefore have additive effects on transcription 
(Diez et. al., 2007). An alternative way of interaction is hypoxia-induced elevation of Notch 
ligand expression, which has been observed for Dll4 (Sahlgren et. al. 2008).
A recent link between Notch and hypoxia involves the protein factor inhibiting HIF-1α 
(FIH-1) in which FIH-1 hydroxylates HIF-1α at asparagine residue 803 in the C-terminal 
transactivation domain (Poellinger and Lendahl 2008). Recent reports show that FIH-1 also 
hydroxylates Notch ICD, and leads to the reduced Notch signaling. Since FIH-1 binds more 
strongly to Notch ICD than to HIF-1α, it raises the possibility that Notch ICD sequesters FIH-
1 away from HIF-1α, relieving HIF-1α from repression by FIH-1, and thus leads to an 
increased recruitment of HIF-1α to HRE-containing regions in hypoxia-induced genes (Zheng 
et. al. 2008).
Therefore, it might speculate that a stem cell residing in a hypoxic niche may require 
HIF-α proteins to fully activate Notch target genes that inhibit differentiation, thereby 
contributing to stem cell self renewal and multipotency (Keith and Simon 2007).
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Figure 1. 11: Schematic depiction of different levels of interaction between Notch and the cellular hypoxic 
response and the potential transcriptional outcome of this cross-talk. Hypoxia can elevate the expression of 
Notch ligands in the Notch signal-transmitting (upper) cell, leading to enhanced Notch signaling in the signal-
receiving (lower) cell. In the signal-receiving cell, transcription of genes, as a result of the interplay between 
Notch ICD and HIF-1α, can fall into at least five potential categories. From left to right: first, a Notch 
transcriptional output that is not affected by hypoxia. Second, HIF-1α is recruited to Notch ICD and enhances 
the Notch transcriptional output (via CSL). Third, HIF-1α and Notch ICD are bound to distinct binding sties and 
have additive effects on transcription. Fourth, Notch indirectly enhances HIF-1α recruitment to HRE sites, 
possibly via sequestering of FIH-1 away from HIF-1α, which may lead to enhance expression of HIF-1α-
responsive genes. Fifth, a HIF-1α transcriptional output that is independent of Notch (Poellinger and Lendahl 
2008).
1.5 Biomaterials
Tissue engineering is the use of cells, biological factors, and biomaterials, alone or in 
combination, with the goal of restoring normal tissue structure and function. Basically, body 
tissue is composed of two components: cells and the surrounding environment. The latter 
includes the extracellular matrix (ECM) for cell proliferation and differentiation as the living 
place of cells and, biosignalling molecules as the nutrients of cells. There are some cases 
where tissue regeneration is achieved by the single or combinational use of the components in 
an appropriate way.  Biomaterials play a key role in designing and creating substitutes for 
ECM and biosignalling molecules to enhance their biological activities. In addition to 
therapeutic applications, biomaterials are also useful in the progress of research and 
development of stem cell biology and medicine (Tabata Y. 2009).
Various synthetic and natural materials, such as polymers, ceramics and metals or their 
composites have been used in different manners. Among them, biodegradable biomaterials are 
important, which is degraded or water solubilized by any process in the body to disappear 
30
from the site implanted. There are two ways of material disappearance. First, the main chain 
of the material is hydrolysed or enzymatically digested to decrease the molecular weight, and 
finally disappears. Second, the material is chemically cross-linked to form a hydrogel 
insoluble in water. When the cross-linking bond is degraded to generate water-soluble 
fragments, the fragments are washed out from the site implanted, resulting in the 
disappearance of material (Tabata Y. 2009). 
Synthetic polymers are generally degraded by simple hydrolysis while natural 
polymers are mainly degraded enzymatically. The synthetic polymers can be modified with 
ease to change their chemical composition and molecular weight, which affect the 
physicochemical property of the materials. Natural polymers of proteins, polysaccharides and 
nucleic acids are available. Their degree of freedom for property modification is small when 
compared with that of synthetic polymers, but they can be chemically modified to produce 
various derivatives (Tabata Y. 2009).
Biomaterials have different applications areas in tissue regeneration therapy and the 
basic stem cell research. Biomaterials play an important role in the preparation of cell 
scaffolds in order to promote cell proliferation and differentiation for in vivo tissue 
regeneration. The biomaterial should be in porous structure for the infiltration of cells, the 
supply of oxygen and nutriens and washout of cell wastes (Lutolf and Hubbell 2005; Chan 
and Mooney 2008). The mechanical property of biomaterial scaffolds is also important. If the 
mechanical strength is low, the scaffold readily deforms in the body
Biomaterials are also used for preparation of a large number of stem cells of high 
quality, because, currently, several stem cells with a high potential for proliferation and 
differentiation are being prepared and applied to a tissue defect to induce tissue regeneration 
(Fernyhough et al. 2008). For example, many researchers of tissue regeneration therapy with 
stem cells, especially MSC, have reported their therapeutic feasibility in tissue regeneration 
(Docheva et al. 2007). In addition, neural stem cells and stem cells isolatable from fat tissue 
have been extensively investigated. Embryonic stem (ES)  and inducible pluripotent stem 
(iPS) cells  have been established and expected as cell sources for transplantation therapy 
(Tabata Y. 2009).
For this purpose, the efficient preparation and proliferation of cells are achieved by 
providing cell culture substrates as the artificial ECM.  The three-dimensional substrate can 
be designed and prepared from biomaterials of cytocompatibility. From the viewpoint of 
nutrients and oxygen supplies, research and development of cell culture methods and 
bioreactors are required (Mironov et al. 2008).
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2. AIM OF STUDY
MSCs are potential therapeutic agents which are applicable in tissue engineering, gene 
delivery, carry high potential for regenerative medicine and do not induce any immune 
reaction. They reside in the niche structures and in order to keep homeostasis, they migrate to 
the site of injury. Despite they are future promise for many disease treatments; there are still 
hurdles to tackle. The amount of MSCs is very low in vivo, therefore their yield should be 
increased. Our aim is to examine the role of environmental factors or conditions on MSC 
biology. 
By using female rat MSCs, we aimed to investigate the following in this thesis;
i. The role of hypoxia and estrogen on MSCs’ maintenance.
ii. The effects of estrogen on the expression of Notch receptor in hypoxia.
iii. Determination of appropriate biomaterials for MSCs expansion.
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3. MATERIALS AND METHODS
3.1 Animals
Adult female Spraque Dawley rats were used for the experiments. The animals were 
kept in the animal holding facility of the Department of Molecular Biology and Genetics at 
Bilkent University under controlled conditions at 22o C with 12 hour light and 12 hour dark 
cycles. They were provided with unlimited access of food and water. The experimental 
procedures have been approved by the animal ethical committee of Bilkent University (Bil-
AEC 2005/2) 
3.2 Isolation of the Bone Marrow from the Animals
After the animals were sacrificed by cervical dislocation for the isolation of the bone 
marrow, the gastrocnemius and biceps regions were shaved with a razor. Then the femur and 
tibia were removed, and the ends of bones were cut and flushed with Dulbecco’s Modified 
Eagle Medium (DMEM) (Hyclone) which contains 10% Fetal Bovine Serum (Hyclone) and 
1% penicillin/streptomycin solution (Hyclone), by using a 5ml syringe (Figure 3.1). The 
mixed media and bone marrow started to be centrifuged at 3000 rpm for 5 min then the media 
was removed and the cells were washed with 1X PBS buffer once. The cells mixed in 1X PBS 
were centrifuged at 2500 rpm for 5 min and then the buffer was removed and cells were 
resuspended in 1X PBS buffer again. The mixture was centrifuged at 2000 rpm for 5 min and 
then the buffer was removed. 1X PBS buffer was added to the cell pellet and cells were 
resuspended once more. The buffer and cells mixture were centrifuged at 1500 rpm for 5 min 
and then cells were resuspended in MesenCult (Stem Cell technologies) media to prepare for 
tissue culturing.        
Figure 3. 1: The isolation of the bone marrow of the rats. A- The gastrocnemius and biceps regions were shaved 
with a razor. B- The femur and tibia were removed. C- The ends of bones were cut. D- Cells were flushed with 
DMEM
3.3 Cell Culture
3.3.1   Cell Number Detection with Cell Count
After the heterogenous bone marrow cells was washed and precipitated, they were 
suspended in 10 ml of MesenCult (Stem Cell Technologies) media and the mixture was 
micropipetted into a hemocytometer. The number of cells in the chamber was determined by 
counting under the light microscope. The cell number was calculated according to the 
following formula: 
concentration of cells in original mixture =
       (http://en.wikipedia.org/wiki/Hemocytometer
3.3.2 MSC Culture
MSCs were cultured by MesenCult media (Stem Cell technologies) with supplement 
(Stem Cell Technologies), and 1% penicillin/streptomycin solution (Hyclone). Next day, the 
media of the tissue culture plates were changed and the majority of the n
were removed. The media of the cells were changed in every 4
sterile 1X PBS prior to the change. The adherent cells on the 14
mostly MSCs. 
3.3.3 Estrogen Treatment
For the estrogen treatment of cells, 17 ß
referred to as “estrogen” in the following sections. The cells which will be treated with 
estrogen were cultured with MesenCult (Stem Cell Technologies) media at first, without 
estrogen. At every media change including the first day, estrogen was added to the media of 
the cells at a physiological concentration of 10
3.4 Hypoxic Condition
On the 14th day of cultured rat MSCs cells were treated with 100 µM CoCl
from the stock solution, in MesenCult (Stem Cell Technologies) medium for 14 h. If 
necessary, estrogen was added at a concentration of 10
prepared. Next day, cells were collected for RNA and protein.  Immunohistochemi
performed on cells grown on cover slip. 
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)
on
-5 days, after washing with 
th day of the cell culture were 
-estradiol (Sigma) was used, which will be 
-7 M (Zhou et al, 2001).   
-7 M after 100 µM CoCl
-adherent cells 
2 prepared, 
2 solution was 
stry was 
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3.5 Biomaterials 
Four different biomaterials were used in this study. Biomaterial designated as ‘CI’ was 
done by mixing hydroxyethyl methacrylate (HEMA) (Sigma, Germany) and 
hydroxypropylchitosan (HPC) (Sigma, Germany) monomers. Biomaterial designated as ‘CII’ 
was prepared by combination of hydroxypropylmethacrylate (HPMA) (Sigma, Germany), 
polyethylene glycol (PEG) (Sigma, Germany) and HPC monomers. Biomaterial designated as
‘CIII’ was done by mixing HEMA, PEG and HPC monomers. Biommaterial designated as ‘C’ 
was done by combination of HPMA and PEG monomers. Five different biomaterials were 
obtained from each group through combination of the monomers with different concentration. 
From CI, CI-A, CI-B, CI-D, CI-E and CI-K were produced. From CII, CII-1, CII-2, CII-3, 
CII-4 and CII-5 were obtained. From CIII, CIII-1, CIII-2, CIII-3, CIII-4 and CIII-5 were 
produced. From C, CA1, CA2, CA3, CA4 and CA5 were done. All biomaterials were 
produced in Gazi University. 
3.5.1 Preparation of Biomaterials
The membrane poly HEMA:HPC, poly HPMA:PEG:HPC, poly HEMA:PEG: HPC 
and poly HPMA:PEG were prepared by photopolymerization. HEMA was distilled under 
reduced pressure before use. The polymerization was carried out in a glass mold (9 cm 
diameter).  Initiator and a-a-azobisisobutyronitrile (AIBN) (Sigma, Germany) (20 mg) were 
dissolved in water and was mixed with monomers mixture as indicated in table1. The 
resulting mixture was equilibrated at 25 ºC for 15 min in the water bath. It was then purged 
with nitrogen for 2 min and was transferred into moulds. It was sealed and exposed to long-
wave ultraviolet radiation for 1 h. After polymerization, the membrane were washed with 
purified water and sterilized with heat at 121 ºC and 15 min. They were stored at 4 ºC. 
Combination of the biomaterials was listed in table 3.1.
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Table 3. 1: Different composition with varying monomer ratio
3.5.2 Growing Rat Bone Barrow Cells on Biomaterials
Before biomaterials were used in the cell culture, they were sterilized under UV light 
for 15 min and then were put on either 24 well plate or 12 well plate. Bone marrow isolated 
cells were seeded directly on biomaterials. One day after cells were seeded, MesenCult (Stem 
Cell Technologies) media was changed. The media was changed every 2 days and cells were 
washed with 1X PBS buffer. On 14th day, the plates were taken and experiments were 
performed.
3.6 Standard Solutions and Buffers can be found in Appendix A
3.7 Colony Forming Assay
MSCs were washed with 1X PBS, then they were air dried. MeOH (cold) was used for 
fixation and left for 5 minutes. Then the cells were washed again with 1X PBS buffer and 
giemsa staining reagent (Carlo Erba) was added and left for 5 min. The reaction of giemsa 
staining was stopped by the addition of tap water and at the end the colonies were stained in 
purple.   
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3.8 Determination of the Gene Expression
3.8.1 Total RNA Isolation from Rat MSCs 
On the 14th day of the cell culture, total RNAs from the MSCs were isolated. The cells 
were first washed with 1X PBS buffer in order to eliminate the non-adherent cells in the 
media. Then the cells were trypsinized at 37oC for 5 min. DMEM (Hyclone) which contains 
10% Fetal Bovine Serum (Hyclone) and 1% penicillin/streptomycin solution (Hyclone) was 
added to the trypsinized cells and centrifuged at 1500 rpm for 5 min. Then the media was 
removed and the precipitated cells were washed with 1X PBS buffer and centrifuged again at 
1500 rpm for 5 min. Next the buffer was removed and the total mRNA was isolated from the 
precipitate by using RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. The 
RNA isolated was stored at -80oC.   
3.8.2 Concentration and Integrity of RNA
The concentration of RNA samples were measured via NanoDrop ND-1000 (Nano 
Drop Technologies, USA) and the quality of RNAs was determined by measuring the ratio 
A260/ <A280. The O.D.260/ O.D.280 ratios were calculated in order to determine if there is a 
phenol, protein or DNA contamination in the RNA samples. The expected values are between 
1,6-2,0. In order to check the integrity of the isolated RNAs, denaturing agarose gel 
electrophoresis was performed. 
3.8.3 Denaturing Gel Electrophpresis
Denaturing gel electrophoresis was performed to check the integrity of the isolated 
RNAs. 1.2% agarose gel was prepared with DEPC-treated water, including 10X MOPS, 3.6% 
formaldehyde and 30 ng/mL ethidium bromide solution. The electrophoresis tank contained 
1X MOPS during running the gels. The samples were prepared by adding 2µl of Agarose Gel 
Loading Dye, 3µl RNA sample and 3µl DEPC-treated H2O and were kept at 65 
oC for 15 
minutes in order to denature the RNA. The gel was run at 90V, for 30 minutes and visualized 
under the transilluminator (Gel-Doc Bio-Rad, USA or Vilber Lourmat, France). Chemicapture 
(Vilber Lourmat, France) software was used in order to take the photographs of the gels.
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3.8.4 The cDNA Synthesis 
The cDNAs were synthesized from the total RNA samples with DyNAmo cDNA 
Synthesis Kit (Finnzymes, Finland) according to the manufacturer's protocol. 2µg RNA was 
mixed with DEPC- ddH2O to a total volume of 14µl and 2µl of oligo(dT) primer was added 
to a total volume of 16 µl. They were incubated at 65 0C for 5 minutes and then chilled on ice 
for 3 minutes. Then 20µl of 2X RT buffer including dNTP mix and 10mM MgCl2  and 4 µl 
of M-MuLV RT RNase H enzyme was added to the mixture and incubated at 25 0C for 10 
min, 45 0C 45 min, and 850C 5 minutes, respectively. The cDNAs were stored at -20 0
3.9 RT- PCR
3.9.1 Primer Design
We have designed primers (Table 3.2) for, Notch1, Notch2, Notch3, Notch4, beta-
actin, CD90, CD34, CD29, CD45 and CD71. The cDNA sequences of the rat homologues of 
these genes are available at the Ensemble database. The Ensemble Accession numbers of the 
rat homologues of Notch1 is ENSRNOT00000008312; Notch2 is ENSRNOT00000025718,
Notch3 is ENSRNOT00000037456, Notch4 is ENSRNOT00000000513, CD90 is 
ENSRNOT00000008685, CD 34 is ENSRNOT00000010148, CD 29 is 
ENSRNOT00000014785, CD 71 is ENSRNOT00000002407, CD 45 is 
ENSRNOT00000060292 and beta- actin is ENSRNOT00000042459
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Table 3. 2: The sequences and the sizes of the primers
Notch 1
(200 bp)
Forward
Reverse
: 5'-TCAACACACTGGGCTCTTTC -3'
: 3'-CCCTCATAACCTGGCCATACA-5'
Notch 2
(220 bp)
Forward
Reverse
:5’-TGATGAGCAGGACAGGAGA-3’
:5’AACCGCAAGCAGATAGAGGA-3’
Notch 3
(225 bp)
Forward
Reverse
:5’-AACTGCCGAAGCGACATAGA -3’
:5’-GAAGCCAGGAAGACAAGCAC-3’
Notch 4
(193 bp)
Forward
Reverse
:5’-ACCTTTCATCTCTGCCTCTGTC -3’
:5’- CCTGGGCTTCACATTCATCTC-3’
CD 90
(394 bp)
Forward
Reverse
:5’- CCAGTCATCAGCATCACTCT-3’
:5’- AGCTTGTCTCTGATCACATT- 3’
CD 34
(281 bp)
Forward
Reverse
: 5’- TGTCTGCTCCTTGAATCT -3’
: 5’- CCTGTGGGACTCCAACT- 3’
CD 29
(190 bp)
Forward
Reverse
: 5’-ACTTCAGACTTCCGCATTGG -3’
: 5’- GCTGCTGACCAACAAGTTCA-3’
CD 71
(182 bp)
Forward
Reverse
:5’-ATGGTTCGTACAGCAGCAGA -3’
:5’- CGAGCAGAATACAGCCATTG-3’
CD 45
(175 bp)
Forward
Reverse
: 5’- ATGTTATTGGGAGGGTGCAA-3’
: 5’- AAAATGTAACGCGCTTCAGG-3’
Beta actin
(65 bp)
Forward
Reverse
: 5’-CTGGCCTCACTGTCCACCTT-3’
: 5’-GGGCCGGACTCATCGTACT-3’
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The RT-PCR reaction was performed by using two different Taq polymerase enzymes. 
The reaction ingredients used in RT- PCR reactions are shown in Table 3.3 and Table 3.4, and 
the conditions of notch receptor PCR reactions are shown in Figure 3.2 and the conditions of 
PCR reactions for CD markers are shown in Figure 3.3.
             Table 3. 3 PCR mixture with Taq Polymerase
PCR Mixture Volume
cDNA 1µl
10x Taq Buffer 2.5µl (1X)
10mM dNTP 0.5µl (0.2µM)
50mM MgCl2 0.75µl (1,5mM)
Forward Primer 1µl  (10 pmol)
Reverse Primer 1µl (10 pmol)
Taq DNA polymerase 0.5µl (1U)
ddH2O 17.75 µl
Total 25µl
      
Table 3. 4: PCR mixture with Phire Hot Start DNA Polymerase
Reaction Mixture Volume
cDNA 1 µl
5x Reaction Buffer ( Finnzymes, Finnland) 4 µl (1X)
Forward Primer (Invitrogen) 1 µl (10 pmol)
Reverse Primer (Invitrogen) 1 µl (10 pmol)
10 mM dNTP (MBI Fermentas) 0,4 µl (0,2mM)
Phire Hot Start DNA Polymerase (Finnzyme, Finland) 0,4 µl (1U)
ddH2O 12,2 µl
Total 20 µl
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Figure  3. 2: PCR conditions and cycles 
3.10 Agarose Gel Electrophoresis
2% agarose gel was prepared with 1X TAE Buffer and 1 mg/ml ethidium bromide 
solution. Samples were prepared by addition of 3μl Agarose Gel Loading Dye to 10μl of 
cDNA sample and loaded to the agarose gel. The gel was run at 120V for 30 minutes and 
visualized under transilluminator (Gel-Doc Bio-Rad, USA or Vilber Lourmat, France). 
Chemicapture (Vilber Lourmat, France) software was used to take photographs of the gels. 
The gene Ruler DNA Ladder Mix (Fermentas, #SM0331) was used as a marker and 5µl was 
loaded to every gel.
3.11 Protein Expression
3.11.1 Total Protein Isolation from the MSCs
The total proteins of the MSCs were isolated on the 14th days of the cell culture. The 
cells were washed with 1X PBS buffer twice in order to wash out the non adherent cells. Then 
the cells were scraped with a scraper and put into a 15 ml falcon tube. Then the mixture was 
centrifuged at 1500 rpm for 5 minutes. The 1X PBS was removed and the precipitate was 
suspended in lysis buffer which was prepared freshly and checked against any protein 
contamination with Bradford reagent prior to use. The mixture was left on ice for 30 min and 
mixed gently every 5 -10 minutes. Then the mixture was centrifuged at 13000 rpm for 20 
minutes. The supernatant which contained the proteins was taken to a separate eppendorf 
tube. It was first dipped into liquid nitrogen for a few seconds and then stored at -800C.
3.11.2 Protein Quantification
Protein quantification was made with Bradford assay. A standard curve was made by 
using 10 different BSA concentrations as in Table 3.5. A standard curve was formed by 
measuring the different BSA concentrations at a fixed wavelength of 595 nm. A formula was 
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derived from the graph derived by putting the O.D. measurements to the y axis and BSA 
amount to the x axis. Then a second set of measurements was made by taking the lysis buffer 
sample containing 900µl Bradford reagent+98µl ddH2O+ 2µl lysis buffer as blank. The other 
samples contained 900µl Bradford reagent+98µl ddH2O+ 2µl protein sample and was 
measured at 595 nm fixed wavelength as well. The O.D. measurements were put to the 
formula derived from the standard BSA concentrations, and the concentrations of the proteins 
were derived. 
Table 3. 5 The standards used for the derivation of the standard curve for protein concentration detection
Standards Std1 Std2 Std3 Std4 Std5 Std6 Std7 Std8 Std9 Std10
BSA(1μg/μl) 0 μl 2,5μl 5 μl 7,5μl 10μl 12,5μl 15μl 20μl 25μl 35μl
ddH2O 100μl 97.5μl 95μl 92.5μl 90μl 87.5μl 85μl 80μl 75μl 65 μl
Bradford 
Reagent
900μl 900μl 900μl 900μl 900μl 900μl 900μl 900μl 900μl 900μl
3.12 Western Blotting
3.12.1 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The protein samples were separated by SDS-PAGE gel with 7.5% resolution gel, and 
5% stacking gel. The proteins were loaded with a concentration of 50ug. A total volume of 
25μl was loaded to the gel which contained the protein, 2% cracking buffer containing 10% ß-
mercaptoethanol. The samples were left at 900C for 5 minutes and then they were put on ice 
for 5 minutes. The PageRuler Prestained Protein Ladder (SM06510, MBI Fermentas, Ontario, 
Canada) was used as a protein molecular weight marker and 5μl was loaded for each gel. The 
gel was run at 80 volts in 1X cold running buffer until the proteins passed from the stacking 
gel to the resolution gel. Then the gel was run at 120 volts until the dyes reached the end of 
the glass and was stopped. The gel was removed from between the glasses. After the stacking 
part of the gel was removed and washed with dH2O, it was put in the semi-dry transfer buffer.
3.12.2 Transfer of Proteins to the Membrane
The proteins were transferred onto the membrane by semi-dry transfer. 4 Whatman 
papers, and the resolution part of the SDS-PAGE gel which are at the sizes of 5,5 cm to 8,5cm 
were left in the semi-dry transfer buffer for 10 minutes. The membrane was left in MetOH for 
30 seconds, in dH2O for 2 minutes, and then in semi-dry transfer buffer for 10 minutes. Then 
two of the Whatman papers, the membrane, the gel, and 2 more Whatman papers were put on 
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to the semi-dry transfer apparat (BioRad) in this order. The bubbles between the layers were 
removed and the transfer was made at 0,16 Ampere for 55 minutes. After the transfer was 
completed, the membrane was washed 5 minutes with 1X TBS-T buffer before the proteins 
were immunologically detected.
3.12.3 Immunological Detection of Immobilized Proteins
After washing, the membrane was left in the blocking solution for 1 hour at RT on an 
orbital shaker. Primary antibody of Hydroxy-HIF-1alpha (D43B5 Cell Signaling Technology, 
USA) was prepared in 5% BSA dilution buffer and was left overnight at 4oC. Primary 
antibodies of ER-a (MC-20 sc-542 Santa Cruz Biotechnologies), ER-b (H-150 sc-8974 Santa 
Cruz Biotechnologies) were prepared in block solution at 1/200 concentration and was left 
overnight at 4oC. The following day the membrane was washed with 1X TBS-T three times 
for 5 minutes. They were incubated with the secondary antibody of Anti-Rabbit IgG, HRP 
(Cell Signaling Technology, USA) at a concentration of 1:2500 for 1 hour at RT on an orbital 
shaker (Thermolyne). The membrane was washed again three times for 5 minutes. ECL Plus 
Detection Reagent (Amersham Biosciences, New Jersey, USA) was added on to the 
membrane and left for 5 minutes. The excess detection reagent was drained off, the membrane 
was placed on glass, and covered with stretch film. The wrapped glass was placed in a x-ray
film cassette. Films were exposed to x-ray for between 30 seconds and 1 minute, respectively. 
After exposure, the films were developed (Amersham). 
3.12.4 Coomassie Blue Staining of the Gel and Membrane 
The membrane and gel were left in the staining solution for 30 min, and then they were 
left in destaining solution overnight, by changing the solution on the membrane and gel each 
time the colour of the destaining solution turned into blue.  
3.13 Immunohistochemistry Staining
The cells were grown on cover slips (Deckglaser 100 No.1 12mm) in the cell culture 
plates. The plates were taken from the 37oC incubator and the media was removed. The cells 
were washed twice with 1X PBS and fixed with cold MeOH for 10 minutes. The cells were 
washed again with 1X PBS twice and left in 3% H2O2 for 15 minutes. After washing three 
times with 1X PBS, the cells were left in blocking solution for 30 minutes at RT. After the 
completion of the blocking step, the cells were incubated with Notch 1 antibody (M-20 sc-
6015 Santa Cruz Biotechnologies) at a concentration of 1:200, Notch 3 antibody (M-20 sc-
832 Santa Cruz Biotechnologies) at a concentration of 1:200, Notch 4 antibody (M-18 sc-
32636 Santa Cruz Biotechnologies) at a concentration of 1:200. The samples were left in the 
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antibody solution for 16 hours at 4oC. The next day the cells were taken and washed with 1X 
PBS twice. The secondary antibodies of Anti-Goat-FITC (Sigma) with 1:5000 dilution for 
Notch1, Notch3 and Notch4 antibodies were added and incubated for 1 hour at RT in the 
dark. After this incubation, the cells were washed twice with 1X PBS. 100μl of Biotin-link 
yellow solution (Dako, Carpinteria, USA) was added and left for 10 min. The cells were 
washed with 1X PBS twice and 100μl Streptavidin-HRP red solution (Dako, Carpinteria, 
USA) was added and left for 10 min. Cells were washed with 1X PBS twice and then 
DAB+Chromogen (Dako, Carpinteria, USA) substrate prepared by dissolving 1 drop of 
DAP+Chromogen reagent in 1ml DAB + Substrate Buffer (Dako, Carpinteria, USA) solution 
was added and incubated until brownish color was observed. Cells then were washed with tap 
water three times. Hemoatoxylene solution was added for counterstain and left for 1-1.5 min. 
Cells were washed with tap water for three times and then the specimens were mounted using 
mounting medium (Dako,USA) and covered for further studies. The photos of the slides were 
taken with the light microscope 40X objectives (Leica TCS/SP5, JAPAN) without water 
immersion equipped with Lecic software. 
3.14 Immunofluorescent Staining
The cells were grown on cover slips (Deckglaser 100 No.1 12mm) in the cell culture 
plates. The plates were taken from the 37oC incubator and the media was removed. The cells 
were washed twice with 1X PBS and fixed with MeOH for 10 minutes. Then the cells were 
washed again with 1X PBS twice and left in 3% H2O2 for 15 minutes. After washing three 
with 1X PBS, the cells were left in blocking solution for 30 minutes at RT. After the 
completion of the blocking step, the cells were incubated with CD90 antibody (Chemicon-
MAB1406) at a concentration of 1:500 and CD34 antibody at a concentration of 1:500 (sc-
7324, Santa Cruz Biotechnologies). The samples were left in the antibody solution for 1 hour 
at RT. The cells were taken and washed with 1X PBS twice. The secondary antibodies of 
Anti-Mouse-FITC (Sigma-F2012-1ML) with 1:100 dilution for CD34 and CD 90 antibody in 
block solution were added and incubated for 1 hour at RT in the dark. After the secondary 
incubation, the cells were washed twice with 1X PBS. After the washing, the specimens were 
mounted using UltraCruz (Santa Cruz) mounting medium with DAPI.  CD90, CD34 and 
DAPI staining were investigated under the fluorescent microscope (Leica TCS/SP5, JAPAN) 
equipped with Lecic software for image analysis at an excitation wavelength 490nm for FITC 
and 359nm for DAPI. The images were taken by 40X objectives without water immersion. 
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3.15 In Situ Cell Death Detection (TUNEL ASSAY)
DNA fragmentation was detected in situ by TdT- (terminal deoxynucleotidyl 
transferase) mediated fluorescein-dUTP labeling kit (Roche Diagnostics, Mannheim, 
Germany). 14th day of cells which was adherent to the cover slips (Deckglaser 100 No.1 
12mm) washed with 1X PBS twice and then some groups of cells were treated with 
MesenCult medium, some groups of cells treated with MesenCult medium with CoCl2, some 
groups of cells were treated MesenCult medium with estrogen and, some group of cells were 
treated with MesenCult medium containing CoCl2 and estrogen, for 14h. Next day, cells were 
washed with 1X PBS and were fixed in freshly prepared 4% paraformaldehyde in PBS for 1 
hour at room temperature. Then the cells were washed with 1X PBS for 3 times and incubated 
with a freshly prepared permeabilisation solution (0.1 % Triton X-100, 0.1 % sodium citrate) 
for two minutes on ice. Then the cells were washed again with 1X PBS twice, and 50 μl of 
TUNEL reaction mixture was added onto each sample and incubated for one hour at 370C in 
the dark in a humidified chamber. The samples were washed with 1XPBS twice and cover 
slips then were closed by UltraCruz (Santa Cruz) mounting medium with DAPI. Slides were 
then analyzed by fluorescent microscopy (Leica TCS/SP5, JAPAN) equipped with Lecic 
software for image analysis at an excitation wavelength 490nm and 359nm for DAPI. Positive 
cells were counted by 40X objectives. As negative control, we incubated the slides in the 
absence of terminal deoxynucleotidyl transferase. For positive controls, the samples were first 
treated for 10 minutes with DNaseI (Fermentas- EN0521) at a concentration of 0,4u/μl at RT 
to induce DNA strand breaks prior to labeling procedures, and then incubated with 50 μl of 
TUNEL reaction mixture. The samples were kept at dark at 40C.
3.16 BrdU incorporation assay
14th day of rat bone marrow cells grown on 75cm flask (Greiner Bio-One, Germany) 
were trypsinized at 37oC for 2 min after washing with 1X PBS twice. DMEM (Hyclone) 
which contains 10% Fetal Bovine Serum (Hyclone) and 1% penicillin/streptomycin solution 
(Hyclone) was added to the trypsinized cells and centrifuged at 1500 rpm for 5 min. Then the 
media was removed and was washed with cold 1X PBS and centrifuged again at 1500 rpm for 
5 min. Cells were resuspended in MesenCult medium with or without estrogen and 50000 
cells were seeded on 18mm cover slip (Dechglasser). After 50% confluency was obtained, 
some groups of cells were treated with MesenCult medium, some groups of cells treated with 
MesenCult medium containg CoCl2, some group of cells treated with MesenCult medium 
containg estrogen, and some groups of cells were treated with MesenCult medium containing 
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CoCl2 and estrogen, for 14h. Next day, cells were treated with BrdU prepared by mixing 
10mg/ml BrdU in 10mL MesenCult medium, in MesenCult with estrogen, in MesenCult with 
CoCl2 and in MesenCult with estrogen and CoCl2. Cells were incubated at 37
oC for 1h. After 
incubation of BrdU, cells were washed with 1X PBS twice then fixed with 70%  cold ethanol 
for 10 min. Cells were washed with 1X PBS twice again and then cells were incubated with 
2N HCl for 20 min at RT. Cells were washed with 1X PBS for three times. Block solution 
was added and left for 15 min. After the removal of the block solution, mouse anti-BrdU 
primary antibody (MO744,Dako, USA) prepared in block solution was added at a 
concentration of 1:500 and incubated for 1h at RT.  The cells were washed with block 
solution three times and as a secondary antibody, Anti-Mouse-FITC (Sigma-F2012-1ML) 
with 1:100 dilution was added and incubated for another 1h at RT in the dark. Cells were 
washed with the block solution three times and cover slips then were closed on slides by 
UltraCruz (Santa Cruz) mounting medium with DAPI. Slides were then analyzed by 
fluorescent microscopy (Leica TCS/SP5, JAPAN) equipped with Lecic software for image 
analysis at an excitation wavelength 490nm for FITC and 359nm for DAPI. Positive cells 
were counted. 
3.17 In Silico Analysis
3.17.1 Finding Transcription Factors
10000bp upstream sequence of Notch1 from the first exon was found by using 
BioMart. Transcription factors that bind this region was found by using MatInspector 
database, which is a software tool that utilizes a large library of matrix descriptions for 
transcription factor binding sites to locate matches in DNA sequences.(Cartharius et al., 
2005). The sequence of 10000bp upstream region of Notch1 was entered as FASTA format to 
the MatInspector. Transcription factor binding sites weight matrices then was chosen. 
Transcription factors binding to the sequence was selected whose core similarity between 0.9-
1, and whose matrix similarity is greater than 0.8. The maximum core similarity of 1.0 is only 
reached when the highest conserved bases of a matrix match exactly in the sequence. Matrix 
similarity takes into account all bases over the whole matrix length. A perfect match to the 
matrix gets a score of 1.00 (each sequence position corresponds to the highest conserved 
nucleotide at that position in the matrix), a "good" match to the matrix usually has a similarity 
of >0.80 (Cartharius et al., 2005). 
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3.17.2 Finding Estrogen induced Transcription Factors
Publicly available datasets were collected from Gene Expression Omnibus (GEO) 
(Table 3.6). 12 microarrays were used for this study. The datasets were normalized with RMA 
using BRB-tool which uses Bioconductor R packages when raw .cel files were available, if 
unavailable, the series matrix files were used and global median normalization was performed 
over the normalized data for each GSM, separately. After normalization step, one-way 
ANOVA (p<0.001) was applied to the normalized data. Estrogen upregulated genes were 
selected by drawing scatter plot in BRB-tool, according to the experimental setup of each 
analyzed microarray
Table 3. 6: Publicly available gene expression data from estrogen studies on cell lines
GSE NO Institution Author Cell Type Platform Data 
Source
Number 
of Arrays
Data 
Process
Pubmed ID
GSE1153 University of 
Illinois
Stossi F. et.al., 
2004
U2OS HG_U95A Series 
Matrix
20 MAS 5.0 15033914
GSE2292 Mayo Clinic Monreo DG. 
et.al., 2005
U2OS HG-Focus Cel 
File
45 RMA 15802376
GSE9757 University of 
Rochester
Nott SL. et.al., 
2009
MDA-MB-
231
HG-
U133_Plus_2
Cel 
File
12 Affy. signal 
method
19321454
GSE9758 University of 
Rochester
Nott SL. et.al., 
2009
MDA-MB-
231
HG-
U133_Plus_2
Cel 
File
12 Affy. signal 
method
19321454
GSE9759 University of 
Rochester
Nott SL. et.al., 
2009
MDA-MB-
231
HG-
U133_Plus_2
Cel 
File
18 Affy. signal 
method
19321454
GSE11352 Genome 
Institute of 
Singapore
Lin CY et.al., 
2oo7
MCF-7 HG-U133 
Plus2
Cel 
File
18 RMA 17542648
GSE11506 Northwestern 
University
Lin Z. et.al., 
2007
MCF-7 HG-U133 
Plus2
Cel 
File
9 RMA 17510434
GSE2251 Unilever Moggs JG. 
et.al., 2005
MDA-MB-
231
HG-U133A Series 
Matrix
12 MAS 5.0 15821115
GSE4025 University of 
Illinois
Frasor J. et.al., 
2006
MCF-7 HG-U133A Series 
Matrix
17 RMA 16849584
GSE4648 Mass General 
Hospital Cancer 
Center
Coser KG. 
et.al., 2003
MCF/BUS HG-U133A Series 
Matrix
34 MAS.5.0 14610279
GSE4006 University of 
Illinois
Chang EC. 
et.al., 2006
MCF-7 HG-U133A Series 
Matrix
12 GCRMA 16809442
GSE11324 Baylor College 
of Medicine
Carroll JS. et.al, 
2006
MCF-7 HG-U133 
Plus2
Cel 
File
12 RMA 17013392
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Summary of the mentioned microarray studies is explained below:
Gse1153: U2OS human osteosarcoma cells were stably transfected with human ER
or ERß The U2OS-ER cells were grown in MEM with phenol red supplemented with 15% 
fetal bovine serum, 100 U penicillin/ml, 100 µg streptomycin/ml, and 400 µg G418/ml. Before 
use in experiments, cells were grown in MEM without phenol red and supplemented with 5% 
charcoal-dextran-treated fetal bovine serum for at least 4 d before the start of E2 treatment. 
Cells were treated with 10 nM E2 for 4, 8, 24, or 48 h. Control cell samples were also treated 
with 0.1% ethanol control vehicle for 48 h (Stossi F. et.al., 2004).
Gse2292: The U2OS-ER , U2OS-ER, and U2OS-ER /ß cells pretreated with 100 
ng/ml Dox for 24 h in CS-FBS media. The cells were then treated with 100 ng/ml Dox plus 
ethanol control, 10 nM E2, or 10 nM 4HT for 24 h (Monroe DG. et.al., 2005)
Gse9757: Cells were infected with the recombinant adenovirus bearing no cDNA or 
cDNA for ER for 48h. Infected cells were then treated with 1 nM Estradiol 17beta for 6h 
(Nott SL. et.al., 2009). 
Gse9758: Cells were infected with the recombinant adenovirus bearing no cDNA or 
cDNA for ER 203/204/211E (3411E) for 48h. Infected cells were then treated with 1 nM 
Estradiol 17beta for 6h (Nott SL. et.al., 2009)  . 
Gse9759: Cells were infected with the recombinant adenovirus bearing no cDNA or a 
cDNA for ER, or cDNA for ER mutant defective in binding to ERE (ERbDBD) for 48 
hours. Infected cells were then treated with 1 nM Estradiol 17beta for 6h (Nott SL. et.al., 
2009).
GSE11352: MCF-7 cells were grown in D-MEM/F-12 supplemented with 10% FBS.  
Cells were washed with PBS and incubated in phenol red-free D-MEM/F-12 medium 
supplemented with 0.5% charcoal-dextran stripped FBS for 24 h in preparation for 17β-
estradiol (E2) treatment.  MCF-7 cells were treated with 10 nM E2 for 12, 24, and 48 h (Lin 
CY. et.al., 2007) 
Gse11506: MCF7 cells were treated with vehicle or E2 at a concentration of 10E-9 
mol/L for 3 and 6 h (Lin Z.et.al., 2007) 
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GSE 2251: ER-negative MDA-MB-231 breast cancer cells were infected  with 
recombinant adenovirus encoding full-length human ER (Ad-ER) or control vector (Ad-
LacZ) for 24 h, and treated with 0·01% ethanol (vehicle control) or 10-8 M 17beta-estradiol 
(E2) for 48h (Moggs JG. et.al., 2005)
GSE 4025: MCF-7 cells expressing endogenous ERalpha were infected with 
adenovirus carrying either estrogen receptor beta (AdERb) or no insert (Ad) at multiplicity of 
infection (moi) of 10. Cells were infected with adenovirus for a period of 48hr before 
treatment with ligand (vehicle control, 10nM 17beta-estradiol, or 10nM hydroxytamoxifen) 
for a additional period of 24hr before harvest (Frasor J. et.al., 2006)
GSE4668: MCF7/BUS cells were maintained in DMEM supplemented with 
5%FBS.Before the treatment, cells were washed three times with phenol red-free DMEM 
supplemented with 5% charcoal-dextran stripped FBS and then grown in the presence of 
varying concentrations of E2 (0 pM, 10 pM, 30 pM, 60 pM, and 100 pM) for 48 hours. In 
another experiment, MCF7/BUS cells were subjected to hormone starvation for 0, 1 or 2 days 
(Coser KR. et.al., 2003)
Gse4006: MCF-7 cells expressing endogenous ERalpha were infected with adenovirus 
carrying either estrogen receptor beta (AdERb) or no insert (Ad) at multiplicity of infection 
(moi) of 5 or 50. Cells were infected with adenovirus for a period of 48hr before treatment 
with ligand (vehicle control or 10nM 17beta-estradiol) for a additional period of 24hr before 
harvest (Chang et al, 2006)
GSE11324:  MCF7 cells were grown in a hormone-deprived media for 24 hours 
before the treatment. Then, cells were stimulated with 100 nM estrogen for 0, 3, 6 or 12 hours 
(Carroll, Meyer et al. 2006).
3.17.3 Finding Common Genes
The intersect of the genes found by MatInspector (section 3.17.1) and estrogen 
upregulated genes (section 3.17.2) was found by WebGestalt tools, stands for WEB-based 
GEne SeT AnaLysis Toolkit, incorporated information from different public resources. 
WebGestalt is designed for functional genomic, proteomic and large scale genetic studies 
from which high-throughput data are continuously produced (Zhang B. et. al., 2005). 
Transcription factors list coming from MatInspector was uploaded into Webgestalt. The gene 
lists coming from each reanalyzed microarray were uploaded into the database as well. 
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3.18 Statistical Analysis
The statistical difference between two groups was analyzed by the two-tailed, Student’s t test 
using Microsoft Office Excel. Significant difference between two groups was declared if p < 
0.05.
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4. RESULTS
4.1 Characterization of Rat MSCs
First isolated bone marrow cells were examined for the expression of mesenchymal stem 
cell markers (CD29, CD71 and CD90) and hematopoietic cell markers (CD34, CD45). By 
using RT-PCR, we showed that these cells express CD29, CD71 and CD90 but not CD34 and 
CD45 (Figure 4.1) Immunoflourescence staining of these cells revealed the presence of CD90 
and absence of CD34 at the protein level (Figure 4.2). 
Our results showed that isolated bone marrow cells are MSCs, suggesting that isolated 
cells are not mixed with HSC or other cell types. Therefore, we obtained a population of 
MSCs after 14 days.   
Figure 4. 1: The expression of CD markers in rat bone marrow isolated cells after 14 days.
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Figure 4. 2: The expression of CD90 (A) and CD34 (B) in bone marrow isolated cells after 14 days. (C) is 
negative control. Green fluorescence signal was from FITC-secondary antibody, while blue fluorescence signal 
was from nuclear DNA counterstained with DAPI. The magnification was 40X.
4.2 Role of Hypoxia and Estrogen in MSCs Biology
We wanted to test whether two physiological stimulus play a role in MSCs biology by 
acting together. In order to do this, hypoxic conditions were mimicked by treating cells by 
CoCl2. Estrogen was at the dose of 10
-7 M given together with 100µM CoCl2 in order to 
compare the effects of estrogen on MSCs in hypoxic condition. 
4.3 Characterization of MSCs after CoCl2 treatment
In order to establish a hypoxic condition, female rat bone marrow isolated cells were 
treated with 100 µM CoCl2, as indicated in materials and methods, after 14 days.  In order to 
investigate the effect of estrogen in hypoxic condition 10-7 M estrogen was also mixed with 
CoCl2 and cells were treated with this mixture.
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In order to detect whether bone marrow MSCs cells displayed the feature of MSCs after 
CoCl2 treatment, the expression level of MSCs markers were controlled by RT-PCR (Figure 
4.3). 
Figure 4. 3: Expression levels of CD90, CD29, CD71, CD34, CD45. MSCs+CoCl2   represents mesenchymal 
stem cell treated with CoCl2, MSCs+est+CoCl2 represents mesenchymal stem cell treated with estrogen and 
CoCl2, MSCs represents mesencymal stem cell without treatment, MSCs +est represents mesencymal stem cells 
treated with estrogen 
As shown in Figure 4.3, the cells expressed mesenchymal stem cell markers but not 
hematopoetic markers after CoCl2 treatment, suggesting that CoCl2 treatment did not alter the 
characteristics of these cells.  
4.4 Expression of HIF-1upon CoCl2 treatment. 
Cellular response to hypoxia is manifested by the activation of the hypoxia-inducible 
factor-1 (HIF-1) which consists of the O2-regulated HIF-1 subunit and the O2-independent 
HIF-1 subunit. Under normoxia, HIF-1 protein becomes hydroxylated at proline-402 and 
proline-564 in its O2-dependent degradation (ODD) domain and is targeted by the von Hippel-
Lindau protein for proteasome-mediated degradation. As pO2 decreases to hypoxic levels, 
HIF-1 is no longer hydroxylated and thus becomes stabilized. Upon nuclear translocation, 
HIF-1 dimerizes with the O2-independent HIF-1 to initiate gene transcription (Lin Q. 
et.al.2006). Therefore, we investigated the expression level of Hif-1upon CoCl2 treatment. 
Since our antibody recognizes hydroxylated Hif-1, we expected to see the accumulation of 
hydroxylated Hif-1 in normoxia, but not in the hypoxic environment which was provided by 
the treatment with CoCl2. As shown in Figure 4.4, hydroxylated Hif -1 was present in 
normoxic but not in hypoxic condition suggesting that we induced hypoxia with CoCl2.
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Figure 4. 4: Expression level of hydroxylated Hif-1 in samples treated with or without CoCl2. Actin was 
used as a loading control. MSCs+CoCl2   represents mesenchymal stem cell treated with CoCl2, 
MSCs+est+CoCl2 represents mesenchymal stem cell treated with estrogen and CoCl2, MSCs represents 
mesencymal stem cell without treatment, MSCs +est represents mesencymal stem cells treated with 
estrogen.  
4.5 Expression of ERand ERin Mesenchymal Stem Cells.
Since estrogen exerts its effects through its receptor, it is important to determine 
whether MSCs express ER and/or ER. Our western blot data showed that MSCs cell are 
positive for both estrogen receptor (Figure 4.5). 
Figure 4. 5: The expression level of ERand ER. Actin is used as a loading control. MSCs represents 
mesencymal stem cell without treatment, MSCs +est represents mesencymal stem cells treated with estrogen.
  
4.6 Colony Forming Assay
Colony forming is one of the distinguishing characteristics of MSCs and reflects their 
functionality. We examined colony formation capability of MSCs in hypoxia and determined 
the role of estrogen treatment in hypoxic condition. Colony forming assay was performed in 
the cells treated only with CoCl2, treated both with CoCl2 and estrogen, treated only with 
estrogen and with no treatment. At least two samples from each sample were taken and 
colonies were counted. Then the average number of colonies among each group was 
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calculated and the results were compared between samples (Figure 4.6). Average number of 
colonies counted on cells treated with CoCl2 was 16.25, average number of colonies counted 
on cells treated with estrogen and CoCl2 was 25, average number of colonies counted on cells 
with no treatment was 13.25 and average number of colonies counted on cells treated with 
estrogen was 19.
Figure 4. 6 The number of colonies after treatment with CoCl2, with CoCl2 and estrogen, with no treatment and 
with only estrogen treatment. *P < 0.05. MSCs+CoCl2   represents mesenchymal stem cell treated with CoCl2, 
MSCs+est+CoCl2 represents mesenchymal stem cell treated with estrogen and CoCl2, MSCs represents 
mesencymal stem cell without treatment, MSCs +est represents mesencymal stem cells treated with estrogen.  
Our results showed that (Figure 4.6), number of colonies increased in cells treated 
with CoCl2 when compared to the normal samples (Fe). Addition of estrogen to the samples 
treated with CoCl2 leads further increase in the colony number. Increase in colony number 
was also observed between samples both treated with estrogen. In addition, increase in colony 
number is higher in cells treated with estrogen and CoCl2.
4.7 TUNEL Assay    
At least two samples from each group were counted for both their total number of cells 
and apoptotic cells. Then the percentage of apoptotic cells to total cells was calculated and 
their averages were taken. The percentage of apoptosis in cells treated with CoCl2 was 4.25, 
the percentage of apoptosis in cells treated with estrogen and CoCl2 was 3.42, the percentage
of apoptosis in cells with no treatment was 3.12 and the percentage of apoptosis in cells 
treated with estrogen was 1.18. While the cells were being counted, only the colonies were 
considered in order to be sure that the cells counted were MSCs. When cells are subjected to 
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hypoxia, they undergo apoptosis and it is known that estrogen prevent apoptosis in some cell 
types. In order to see whether treatment of CoCl2  leads  increase in apoptosis in MSCs and 
whether estrogen decrease apoptosis in MSCs, we performed In Situ Cell death detection as 
described in materials and methods. According to the Figure 4.7, the number of the apoptotic 
cell increased upon CoCl2 treatment when compared to the non-treated samples.  However, 
the rate of apoptosis was decreased when the sample treated with CoCl2 and with estrogen 
together. The percentage of apoptosis was also high in cells treated with CoCl2 and estrogen 
when compared with sample treated with estrogen alone. In addition, percentage of apoptosis 
was also decreased in cells treated only with estrogen when compared with the non-treated 
samples.
Figure 4. 7: The apoptotic cell ratios of cells after treatment with CoCl2, with CoCl2 and estrogen, with no 
treatment and with only estrogen treatment. The number of TUNEL positive cells was divided to the total 
number of cells. MSCs+CoCl2   represents mesenchymal stem cell treated with CoCl2, MSCs+est+CoCl2 
represents mesenchymal stem cell treated with estrogen and CoCl2, MSCs represents mesencymal stem cell 
without treatment, MSCs +est represents mesencymal stem cells treated with estrogen.  
4.8 BrdU Incorporation Assay     
At least two samples from each group were counted for both their total number of cells 
and BrdU positive cells. Then the percentage of BrdU positive cells to total cells was
calculated and their averages were taken. The percentage of proliferation in cells treated with 
CoCl2 was 18.2, the percentage of proliferation in cells treated with estrogen and CoCl2 was 
20.4, the percentage of proliferation in cells with no treatment was 22.6 and the percentage of 
proliferation in cells treated with estrogen was 26.3. While the cells were being counted, only 
the colonies were considered in order to be sure that the cells counted were MSCs. While the 
cells were being counted, only the colonies were considered in order to be sure that the cells 
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counted were MSCs Since hypoxia is an important factor for the stem cell self-renewal, we 
investigated how proliferation of MSCs was changed upon CoCl2 treatment and estrogen 
treatment with BrdU incorporation assay (Figure 4.8). 
Figure 4. 8: The proliferation rate of MSC after treatment with CoCl2, with CoCl2 and estrogen, with no 
treatment and with only estrogen treatment. Cells were incubated BrdU for 1h. The number of BrdU positive 
cells was divided to the total number of cells. MSCs+CoCl2   represents mesenchymal stem cell treated with 
CoCl2, MSCs+est+CoCl2 represents mesenchymal stem cell treated with estrogen and CoCl2, MSCs represents 
mesencymal stem cell without treatment, MSCs +est represents mesencymal stem cells treated with estrogen.      
Parallel to our TUNEL data, our BrdU incorporation assay result revealed that 
proliferation of MSC was decreased in cells treated with CoCl2 when compared with non-
treated samples. However, proliferation of MSC increased when estrogen was added to the 
cells treated with CoCl2. The proliferation rate increased upon estrogen treatment in non-
treated samples. 
4.9 Expression of Notch Receptors in hypoxic condition and upon estrogen treatment 
in MSCs.    
We investigated the expression levels of notch receptors when cells treated with CoCl2. 
Moreover, we also examined whether estrogen treatment affects the expression level of notch 
receptors in normoxic and hypoxic conditions. We used RT- PCR to determine the expression 
of notch receptors at transcript and used immunohistochemisty for protein level, from 14th day 
cells after treatment with CoCl2, with CoCl2 and estrogen, with no treatment and with only 
estrogen treatment. 
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4.9.1 Expression of Notch Receptors 
In order to check how expression levels of Notch receptors were changed in hypoxic 
condition with or without estrogen, RT-PCR (Figure 4.9) and immunohistochemistry (Figure 
4.10, 4.11. and 4.12) was performed on cells 14th day after treatment with CoCl2, with CoCl2 
and estrogen, with no treatment and with only estrogen treatment.
Figure 4. 9: The expression profile of Notch receptors.  The first lines represent Notch expression. Second line 
represents loading control done with beta-actin.
Our results showed that (Figure 4.9.), the expression of Notch 1 did not change with 
CoCl2 treatment with compared to untreated cells. Moreover addition of estrogen at the 
hypoxic environment did not change the expression. However notch 1 receptor expression 
was decreased when MSCs treated only with estrogen.  The expression of notch 2 receptor did 
not show any change amongst the experimental groups.  Notch 3 receptor expression 
decreased in hypoxic conditions compared to normoxia. Its expression remained unchanged 
upon estrogen treatment at the hypoxic environment. However, Notch 3 level decreased when 
cells were treated with estrogen in normoxic condition. The expression level of Notch 4 was 
increased in the hypoxia compared to normoxia and its expression was further increased when 
estrogen was added to the hypoxic cells. On the other hand, expression level of Notch 4 was 
increased when normoxic cells were treated with estrogen.    
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Figure 4. 10 :The expression of Notch 1 in cells after treatment with CoCl2, with CoCl2 and estrogen, with no 
treatment and with only estrogen treatment. 40X 
At the protein level, the expression level of Notch 1 was denser in cells treated with 
CoCl2 when compared to cells treated without CoCl2 (Figure 4.10). However, unfortunately 
we were not able to measure the levels of notch 1 protein by western blot. Therefore we are 
not able to quantitate its levels.
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Figure 4. 11: The expression of Notch 3 in cells after treatment with CoCl2, with CoCl2 and estrogen, with no 
treatment and with only estrogen treatment. 40X 
When we examined notch 3 by immunohistochemistry, we found that in the hypoxic 
conditions MSCs were stained denser than the normoxic condition (Figure4.11). Again we 
were not able to measure the levels of notch 3 protein by western blot. Therefore we are not 
able to quantitate its levels. 
Finally, notch 4 staining was denser in MSCs in hypoxic conditions than normoxia 
(Figure 4.12). Similar to other notch receptors we were not able to measure the levels of notch 
1 protein by western blot. Therefore we are not able to quantitate its levels 
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Figure 4. 12: The expression of Notch 4 in cells after treatment with CoCl2, with CoCl2 and estrogen, with no 
treatment and with only estrogen treatment. 40X 
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4.10 Bone Marrow Isolated Cells Grown on Biomaterials 
MSCs were growth on 20 different biomaterials, which were produced combinations of 
the different polymer (Table 4.1).  In order to determine whether MSCs were able to attach 
the biomaterials after 14 days, we investigated their morphology their colony forming 
activities. Our data showed that we were able to observe MSC growth on the biomaterials 
designated as “CIII-1”, “CIII-2”, and “CIII-5” (Figure 4.13). In addition, when the bio 
materials were stained with Giemsa to reveal their CFU-F activity, we found that they were 
capable of forming colonies suggesting that biomaterials designated “CIII-1”, “CIII-2”, and 
“CIII-5” are compatible for MSCs (Figure 4.14). Even if, cells grown on CIII-3 displayed 
MSC morphology, they were not able to form colonies. Similar to CIII-3, no MSC-like cells 
were observed on CIII-4 (table 4.2). 
Table 4. 1: Different composition with varying monomer ratio
63
Figure 4. 13: On the 14th day pictures of rat female bone marrow isolated cells grown on biomaterials “CIII”. 
20X objective was used in all pictures but magnification varied between them to obtain better resolution for each 
biomaterial.
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Figure 4. 14: Colonies formed on biomaterials designated as CIII after 14 days culture. 20X objective was used 
in all pictures but magnification varied between them to obtain better resolution for each biomaterial.
Amongst “CI” series of biomaterials “CI-K” provided the best condition to support the 
MSCs compared to other “CI” biomaterials (Figure 4.15). Cells that were grown on “CI-K” 
form colonies (Figure 4.16). MSCs were also able to grow and form colonies when grown in 
biomaterial “CI-A” but not in CI-B and CI-D (Figure 4.15).  Cells grown on CI-E were not 
visualized due to thickness and lack of transparency of the biomaterial. (Table 4.2).      
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Figure 4. 15: On the 14th day pictures of rat female bone marrow isolated cells grown on biomaterials “CI”. 20X 
objective was used in all pictures but magnification varied between them to obtain better resolution for each 
biomaterial 
Figure 4. 16: Colonies formed on CI-A and CI-K biomaterials after 14 days culture. 20X objective was used in 
all pictures but magnification varied between them to obtain better resolution for each biomaterial.
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Our data showed that we were able to observe MSC growing on the biomaterials 
designated as “CA-1” and “CA-2” (Figure 4.17). In addition, when the bio materials were 
stained with Giemsa, it was observed that cells grown on CA-1and CA-2 were capable of 
forming colonies on these biomaterials (Figure 4.18). Although we could not discriminate 
whether cells growing on CA-3 were MSCs (Figure 4.17), we could observe that cells 
growing on CA-3 could form colonies (4.18).  On the other hand, no MSCs cells were 
observed on CA-5, and cells grown on CA-4 were not observed because cells could not 
visualized under microscope both before and after colony forming assay (Table 4.2).     
        
Figure 4. 17: On the 14th day pictures of rat female bone marrow isolated cells grown on biomaterials designated 
as “CA”. 20X 
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Figure 4. 18: Colonies formed on CA-2 and CA-3 biomaterials after 14 days culture. 20X objective was used in 
all pictures but magnification varied between them to obtain better resolution for each biomaterial.
Table 4. 2: Summary of observed cell morphology and observed colony formation on each Biomaterials. (+/-) 
represents both MSCs and other cells. 
Bio Materials Presence of MSCs CFU
CA-1 + +
CA-2 + +
CA-3 +/- +
CA-4 - -
CA-5 - -
CI-A + +
CI-B +/- -
CI-D - -
CI-E - -
CI-K + +
All  CIIs - (*) - (*)
CIII-1 + +
CIII-2 + +
CIII-3 + _
CIII-4 - -
CII-5 + +
(*) represents failure in the visualization of CII due to thickness and  lack of  transparency
4.11 Bioinformatics Analysis
Our aim was to understand whether estrogen regulates the expression of Notch 
receptors, however we were unable to perform western blot for quantification of Notch 
receptor protein levels, we took an indirect approach to overcome this problem. First we 
examined the promoter region of the notch 1 receptor gene for all the transcription factor 
binding sites. Then we extracted available microarray data sets to analyze estrogen-induced 
genes. The genes (transcription factors) that were shown to be upregulated upon estrogen 
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treatment were then searched for the presence of binding sites in 10000 bp upstream notch 
receptor 1 gene promoter. We investigated Notch 1 because it was known that its expression 
was increased upon estrogen treatment in MCF-7 cell lines (Soares R. et.al.2004).    
4.11.1 Transcription Factors on Notch 1 10000bp upstream region
10000bp upstream sequence of Notch1 from the first exon was found by using 
BioMart. Transcription factors that bind this region was found (Table 5.1) by using 
MatInspector database, which is a software tool that utilizes a large library of matrix 
descriptions for transcription factor binding sites to locate matches in DNA 
sequences.(Cartharius et al. 2005). The sequence of 10000bp upstream region of Notch1 was 
entered as FASTA format to the MatInspector. Transcription factors binding to the sequence, 
whose core similarity was between 0.9-1 and whose matrix similarity is greater than 0.8 was 
selected. The maximum core similarity of 1.0 is only reached when the highest conserved 
bases of a matrix match exactly in the sequence. Matrix similarity takes into account all bases 
over the whole matrix length. A perfect match to the matrix gets a score of 1.00 (each 
sequence position corresponds to the highest conserved nucleotide at that position in the 
matrix), a "good" match to the matrix usually has a similarity of >0.80 (Cartharius et al.
2005).  
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Table 4. 3: 574 Transcription Factors binding to 10000bp upstream region of Notch 1 from the first exon.
IRF1 IRF2 IRF3 IRF4 IRF5 IRF6 IRF7 IRF8 ISGG RNF31
EGR1 EGR2 EGR3 EGR4 WT1 ZBTBA ZBTBB EHF ELF1 ELF2
ELF4 ELF5 ELK1 ELK3 ELK4 ERF ERG ETS1 ETS2 ETV1
ETV3 ETV4 ETV5 ETV6 ETV7 FEV FLI1 FLI2 GABA GABPAP
MGC29891 SPDEF SPI1 SPIB SPIC BCL11A BCL11B EVI1 MDS1 PRDM16
GTF2I GTF2IRD1 BACH1 BACH2 MAF MAFA MAFB MAFF MAFG NFE2
NFE2L1 NFE2L2 NFE2L3 NRL PAX3 PAX7 KLF4 EOMES MGA T
TBX1 TBX10 TBX15 TBX18 TBX19 TBX2 TBX20 TBX21 TBX22 TBX23P
TBX4 TBX5 TBX6 ATF1 ATF2 ATF3 ATF4 ATF5 ATF6 ATF7
CREB3 CREB3L3 CREB3L4 CREB5 CREBL1 NFIL3 EBF EBF2 EBF3 FOXN1
TP53 TP73 TP73L KCNIP1 KCNIP2 KCNIP3 KCNIP4 TFCP2 TFCP2L1 UBP1
NR1H3 NR1I2 NR1I3 RARA RARB RARG RXRB RXRA RXRG THRA
VDR BNC1 SMAD1 SMAD2 SMAD3 SMAD4 SMAD5 SMAD9 YY1 NR5A1
CUTL1 CUTL2 GFI1 GFI1B ONECUT1 ONECUT2 ONECUT3 CIC HBP1 HMG4L
HMGA2 SOX1 SOX10 SOX11 SOX12 SOX13 SOX14 SOX15 SOX17 SOX18
SOX21 SOX3 SOX30 SOX5 SOX5P SOX6 SOX7 SOX8 SOX9 SRY
STAT1 STAT2 STAT3 STAT4 STAT5A STAT5B STAT6 ILF2 ILF3 NFAT5
NFATC2 NFATC3 NFATC4 RBPSUH IKZF4 ZNFN1A1 ZNFN1A2 ZNFN1A3 E2F1 E2F2
E2F4 E2F5 E2F6 E2F7 E2F8 TFDP1 TFDP2 TFDP3 INSM1 RREB1
ESR2 ESRRA ESRRB ESRRG NR1D1 NR1D2 RORA RORB RORC HNF4A
NR2C1 NR2C2 NR2E3 NR2F1 NR2F2 NR2F6 ZNF83 E4F1 DEAF1 HAND1
LYL1 NHLH1 NHLH2 SCXA SCXB TAL1 TAL2 TCF12 TCF15 TCF3
ZFHX1B KLF6 ZNF148 ZNF202 ZNF219 ZNF281 KLF10 KLF11 KLF13 KLF16
KLF9 SP1 SP2 SP3 SP4 SP5 SP6 SP7 SP8 HIVEP1
HIVEP3 NFKB1 NFKB2 REL RELA RELB CHES1 FKHL18 FOXA1 FOXA2
FOXB1 FOXB2 FOXC1 FOXC2 FOXD1 FOXD2 FOXD3 FOXD4 FOXD4L1 FOXD4L4
FOXE3 FOXF1 FOXF2 FOXG1 FOXI1 FOXJ1 FOXJ2 FOXJ3 FOXK1 FOXK2
FOXL2 FOXM1 FOXO1A FOXO3A FOXP1 FOXP2 FOXP3 FOXQ1 KLF4 ATF6
MAX MGA MLX MLXIPL MNT MXI1 MYC MYCL1 MYCL2 MYCN
TCF4 USF1 BAPX1 C10orf121 HMX1 HMX2 HMX3 NKX1-1 NKX2-2 NKX2-3
NKX2-5 NKX2-6 NKX2-8 NKX3-1 TITF1 AIRE KLF1 KLF12 KLF15 KLF2
KLF7 KLF8 CBFA2T2 CBFA2T3 CBFB RUNX1 RUNX1T1 RUNX2 RUNX3 NR4A1
NR4A3 CTCF CTCFL PAX5 PPARA PPARAL PPARD PPARG RXRA RXRB
TFAP4 JARID1B BCL6 BCL6B HOXA10 HOXA3 HOXA4 HOXA6 HOXA7 HOXA9
HOXA2 HOXA5 HOXB1 HOXB3 HOXB5 HOXB6 HOXB7 HOXB8 HOXB9 HOXC10
HOXC5 HOXC6 HOXC8 HOXC9 HOXD1 HOXD10 HOXD3 HOXD4 HOXD8 HOXD9
PBX2 PBX3 SRF TBP HNF4A HNF4G NR2C1 NR2C2 NR2E3 NR2F1
NR2F6 ZNF83 POU3F2 POU3F3 POU3F4 POU4F1 POU4F2 POU4F3 POU6F1 MYT1
ST18 SMARCA3 BCL11A BCL11B EVI1 MDS1 PRDM16 ZNF521 CEBPA CEBPB
CEBPE CEBPG CEBPZ LHX1 LHX3 LHX4 LMX1B NANOG OTX1 OTX2
PHOX2B PITX1 PITX2 PITX3 RAX RAX2 TLX1 TLX2 TLX3 NKX6-1
TCF1 TCF2 DBP HLF TEF VBP1 TEAD1 TEAD2 TEAD3 TEAD4
GFI1B EGR1 EGR2 EGR3 EGR4 WT1 ZBTB7A ZBTB7B MAZ ZNF278
RBPSUH RBPSUHL SPZ1 BHLHB2 BHLHB3 HELT HES1 HES2 HES3 HES4
HES6 HES7 HEY1 HEY2 ITGB3BP TAF1 TAF2 TAF6 TAF9 TAF9B
GTF2I GTF2IRD1 ATOH1 NEUROD1 NEUROD2 NEUROD4 NEUROD6 NEUROG1 NEUROG2 NEUROG3
TCF12 TCF3 ZNF238 MEIS1 MEIS2 MEIS3 PKNOX1 PKNOX2 TGIF TGIF2
TGIF2LY GLI1 GLI2 GLI3 GLIS1 GLIS2 GLIS3 ZIC1 ZIC2 ZIC3
ZIC5 ARNT ARNT2 ARNTL ARNTL2 CLOCK EPAS1 HIF1A HIF3A NPAS1
KCNIP1 KCNIP2 KCNIP3 KCNIP4 PLAG1 SMARCA3 PLAGL2 HSF1 HSF2 HSF4
HSFY2 ALX3 ALX4 CART1 ESX1 PURA LEF1 SOX4 TCF7 TCF7L1
NR4A1 NR4A2 NR4A3 TFAP2A TFAP2B TFAP2C TFAP2D TFAP2E NFIA NFIB
NFIX GTF2B
4.11.2 Estrogen Induced Genes 
Publicly available datasets were collected from Gene Expression Omnibus (GEO). 12 
microarrays were used for this study. The datasets were normalized with RMA using BRB-
tool which uses Bioconductor R packages when raw .cel files were available, if unavailable, 
the series matrix files were used and global median normalization was performed over the 
normalized data for each GSM, separately. After normalization step, one-way ANOVA 
(p<0.001) was applied to the normalized data. Estrogen upregulated genes were selected by 
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drawing scatter plot in BRB-tool, according to the experimental setup of each analyzed 
microarray. The details of these experiments are summarized below;
GSE1153
U2OS human osteosarcoma cells were stably transfected with human ER or ERß, 
where cells were treated with 10 nM E2 for , 8, 24, or 48 h. Control cell samples were also 
treated with 0.1% ethanol control vehicle for 48 h (Stossi F. et.al. 2004)l. The series matrix 
files were used and global median normalization was performed over the normalized data. 
50000 genes were found after normalization step. One-way ANOVA (p<0.001) was applied 
to the normalized data and 5200 genes were selected from these 50000 genes. Then, by 
drawing scatter plots in BRB-tool, at least 2 fold increased estrogen upregulated genes were 
found in samples treated with estrogen for 8h,24hand 48h by comparing with the control 
samples treated with ethanol (Table 4.4). 
Table 4. 4: Number of estrogen up-regulated genes in GSE 1153 in different experimental setups. 
Conditions Number of estrogen up regulated genes
No estrogen vs. Era tr./w. estrogen for 8h 23
No estrogen vs. Era tr./w. estrogen for 24h 86
No estrogen vs. Era tr./w. estrogen for 48h 86
No estrogen vs. ERb tr./w. estrogen for 8h 23
No estrogen vs. ERb tr./w.  estrogen for 24h 41
No estrogeb vs. ERb tr./w. estrogen for 48h 47
GSE2292
The U2OS-ER , U2OS-ER, and U2OS-ER /ß cells were treated with estrogen for 
24h. GSE2292 datasets were normalized with RMA using BrB-tool which uses Bioconductor 
R packages because raw .cel files were available. 50000 genes were found after normalization 
step. One-way ANOVA (p<0.001) was applied to the normalized data and 5200 genes were 
selected from these 50000 genes. Then, by drawing scatter plot in BRB-tool, at least 2 fold 
increased estrogen upregulated genes were found in samples treated with estrogen  by 
comparing with the control samples treated with ethanol (Table 4.5.). 
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Table 4. 5: Number of estrogen up-regulated genes in GSE 1153 in different experimental setups
Conditions Number of estrogen up regulated genes
Era tr./w/o. estrogen vs. Era tr./w. estrogen 146
Erb tr./w/o. estrogen vs. ERb tr./w. estrogen 61
ERab tr./w/o.estrogen vs. ERab tr./w estrogen 125
GSE9757, GSE9758 and GSE9759 
In Gse9757, cells were infected with the recombinant adenovirus bearing no cDNA or 
cDNA for ER for 48h. Infected cells were then treated with 1 nM Estradiol 17beta for 6h 
(Nott SL. et.al. 2009). In Gse9758, cells were infected with the recombinant adenovirus 
bearing no cDNA or cDNA for ER 203/204/211E (3411E) for 48h. Infected cells were then 
treated with 1 nM Estradiol 17beta for 6h (Nott SL. et.al. 2009). In Gse9759, cells were 
infected with the recombinant adenovirus bearing no cDNA or a cDNA for ER, or cDNA for 
ER mutant defective in binding to ERE (ERbDBD). for 48 hours. Infected cells were then 
treated with 1 nM Estradiol 17beta for 6h (Nott SL. et.al. 2009). The datasets were normalized 
with RMA using BrB-tool which uses Bioconductor R packages because raw .cel files were 
available. 50000 genes were found after normalization step. One-way ANOVA (p<0.001) was 
applied to the normalized data and 5200 genes were selected from these 50000 genes. Then, 
by drawing scatter plot in BRB-tool, at least 2 fold increased estrogen upregulated genes were 
found in samples treated with estrogen  by comparing with the control samples (Table 4.6).
Table 4. 6: Number of estrogen up-regulated genes in GSE9757, GSE9758 and GSE9759 in different 
experimental setups
Conditions Number of estrogen up regulated genes
No estrogen vs. Era tr./w. estrogen (GSE9757) 111
No estrogen vs. Era(def) tr./w. estrogen (GSE9758) 17
No estrogen vs. ERb tr./w. estrogen (GSE9759) 7
No estrogen vs. ERb(def) tr./w. estrogen(GSE9759) 21
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GSE11352 
MCF-7 cells were treated with 10 nM E2 for 12, 24, and 48 h (Lin CY. et.al. 2007) 
GSE11352 datasets were normalized with RMA using BrB-tool which uses Bioconductor R 
packages because raw .cel files were available. 50000 genes were found after normalization 
step. One-way ANOVA (p<0.001) was applied to the normalized data and 5200 genes were 
selected from these 50000 genes. Then, by drawing scatter plot in BRB-tool, at least 2 fold 
increased estrogen upregulated genes were found in samples treated with estrogen for 12h, 
24h, and 48h by comparing with the control samples treated with ethanol (Table 4.7.).
Table 4. 7: Number of estrogen up-regulated genes in GSE 11352 in different experimental setups.
Conditions Number of estrogen up regulated genes
No estrogen vs. estrogen for 12h 99
No estrogen vs. estrogen for 24h 138
No estrogen vs. estrogen for 48h 174
GSE11506
MCF7 cells were treated with vehicle or E2 at a concentration of 10E-9 mol/L for 3 
and 6 h (Lin Z.et.al. 2007) GSE11506 datasets were normalized with RMA using BrB-tool 
which uses Bioconductor R packages because raw .cel files were available. 50000 genes were 
found after normalization step. One-way ANOVA (p<0.001) was applied to the normalized 
data and 5200 genes were selected from these 50000 genes. Then, by drawing scatter plot in 
BRB-tool, at least 2 fold increased estrogen upregulated genes were found in samples treated 
with estrogen for 3h and 6h by comparing with the control samples (Table 4.8.).
Table 4. 8: Number of estrogen up-regulated genes in GSE 11506 in different experimental setups.
Conditions Number of estrogen up regulated genes
No estrogen vs. estrogen for 3h 108
No estrogen vs. estrogen for 6h 41
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GSE2251
ER-negative MDA-MB-231 breast cancer cells were infected  with recombinant 
adenovirus encoding full-length human ER (Ad-ER) or control vector (Ad-LacZ) for 24 h, 
and treated with 0·01% ethanol (vehicle control) or 10-8 M 17beta-estradiol (E2) for 48h 
(Moggs JG. et.al. 2005) The series matrix files were used and global median normalization 
was performed over the normalized data. 50000 genes were found after normalization step. 
One-way ANOVA (p<0.001) was applied to the normalized data and 5200 genes were 
selected from these 50000 genes. Then, by drawing scatter plots in BRB-tool, at least 2 fold 
increased estrogen upregulated genes were found in samples treated with estrogen by 
comparing with the control samples (Table 4.9.). 
Table 4. 9 Number of estrogen up-regulated genes in GSE 2251 in different experimental setups
Conditions Number of estrogen up regulated genes
ER neg. tr./w/o. estrogen vs. ER neg.tr./w. estrogen 39
ER neg. tr./w/o. estrogen vs. Era tr./w. estrogen 374
GSE4025
MCF-7 cells expressing endogenous ERalpha were infected with adenovirus carrying 
either estrogen receptor beta (AdERb) or no insert (Ad) at multiplicity of infection (moi) of 
10. Cells were treated with vehicle control or treated with 10nM estrogen for 24h (Frasor J. 
et.al. 2006) The series matrix files were used and global median normalization was performed 
over the normalized data. 50000 genes were found after normalization step. One-way 
ANOVA (p<0.001) was applied to the normalized data and 5200 genes were selected from 
these 50000 genes. Then, by drawing scatter plots in BRB-tool, at least 2 fold increased 
estrogen upregulated genes were found in samples treated with estrogen by comparing with 
the control samples (Table 4.10.).
Table 4. 10: Number of estrogen up-regulated genes in GSE4025 in different experimental setups
Conditions Number of estrogen up regulated genes
Era tr./w/o. estrogen vs. Era tr./w estrogen 553
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GSE4668 
MCF7/BUS cells were maintained in the presence of varying concentrations of E2 (0 
pM, 10 pM, 30 pM, 60 pM, and 100 pM) for 48 hours. (Coser KR. et.al. 2003). The series
matrix files were used and global median normalization was performed over the normalized
data. 50000 genes were found after normalization step. One-way ANOVA (p<0.001) was 
applied to the normalized data and 5200 genes were selected from these 50000 genes. Then, 
by drawing scatter plots in BRB-tool, at least 2 fold increased estrogen upregulated genes 
were found in samples treated with estrogen by comparing with the control samples treated 
with ethanol (Table 4.11.).
Table 4. 11 Number of estrogen up-regulated genes in GSE4668 in different experimental setups.
Conditions Number of estrogen up regulated genes
0 pM estrogen vs. 10 pM estrogen 108
0 pM estrogen vs. 13 pM estrogen 318
0 pM estrogen vs. 16 pM estrogen 471
0 pM estrogen vs. 100 pM estrogen 510
GSE4006 
MCF-7 cells expressing endogenous ERalpha were infected with adenovirus carrying 
either estrogen receptor beta (AdERb) or no insert (Ad) at multiplicity of infection (moi) of 5 
or 50. Cells were treated with vehicle control or treated with 10nM 17beta-estradiol for 24hr 
before harvest (Chang EC. et.al. 2006) The series matrix files were used and global median 
normalization was performed over the normalized data. 50000 genes were found after 
normalization step. One-way ANOVA (p<0.001) was applied to the normalized data and 5200 
genes were selected from these 50000 genes. Then, by drawing scatter plots in BRB-tool, at 
least 2 fold increased estrogen upregulated genes were found in samples treated with estrogen 
by comparing with the control samples treated (Table 4.12.).
Table 4. 12: Number of estrogen up-regulated genes in GSE4006 in different experimental setups.
Conditions Number of estrogen up regulated genes
Era tr./w/o. estrogen vs. Era tr./w. estrogen 272
Erab tr./w/o. estrogen vs. Erab tr./w. estrogen (5moi) 309
Erab tr./w/o. estrogen vs. Erab tr./w. estrogen (50moi) 441
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GSE11324
MCF7 cells were grown in a hormone-deprived media for 24 hours before the 
treatment. Then, cells were stimulated with 100 nM estrogen for 0, 3, 6 or 12 hours (Carroll, 
Meyer et al. 2006) GSE11324 datasets were normalized with RMA using BrB-tool which
uses Bioconductor R packages because raw .cel files were available. 50000 genes were found 
after normalization step. One-way ANOVA (p<0.001) was applied to the normalized data and 
5200 genes were selected from these 50000 genes. Then, by drawing scatter plot in BRB-tool, 
at least 2 fold increased estrogen upregulated genes were found in samples treated with 
estrogen for 3h, 6h, and 12h by comparing with the control sample (Table 4.13.).
Table 4. 13:  Number of estrogen up-regulated genes in GSE11324 in different experimental setups.
Conditions Number of estrogen up regulated genes
Estrogen at 0h vs. estrogen at 3h 187
Estrogen at 0h vs. estrogen at 6h 393
Estrogen at 0h vs. estrogen at 12h 1060
4.11.3 Common Genes between TFs found by MatInspector and Estrogen Up-Regulated 
Genes.
The intersects between the gene lists of transcription factors and gene lists of estrogen 
upregulated genes obtained from each reanalyzed microarray datasets according to their 
experimental setup, were found by using WebGestalt tools. (stands for WEB-based GEne SeT
AnaLysis Toolkit), which incorporated information from different public resources. 
WebGestalt is designed for functional genomics, proteomics and large scale genetic studies 
from which high-throughput data are continuously produced (Zhang B. et.al. 2005). 
Transcription factors list coming from MatInspector was uploaded into Webgestalt. Then, 
common genes were found between two different gene lists.  Intersects between transcription 
factors and estrogen up-regulated genes were represented in the tables.  
Table 4. 14: Common genes between reanalyzed GSE1153 datasets and MatInspector
Conditions GSE1153 TF Intersections
No estrogen vs. Era tr./w. estrogen for 8h TF PITX2
No estrogen vs. Era tr./w. estrogen for 24h TF CREB3L4, PITX2
No estrogen vs. Era tr./w. estrogen for 48h TF GLI3, PITX2
No estrogen vs. ERb tr./w. estrogen for 8h TF ELK4, GLI3,SMAD3
No estrogen vs. ERb tr./w.  estrogen for 24h TF SMAD3
No estrogeb vs. ERb tr./w. estrogen for 48h TF ELK4,SMAD3
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Table 4. 15: Common genes between reanalyzed GSE2292 datasets and MatInspector
Conditions TF Intersections
Era tr./w/o. estrogen vs. Era tr./w. estrogen TF ZNF283,MAFF
Erb tr./w/o. estrogen vs. ERb tr./w. estrogen TF HOXC10,NFE2L1
ERab tr./w/o.estrogen vs. ERab tr./w estrogen TF NFIL3
Table 4. 16: Common genes between reanalyzed GSE9757,GSE9758 and GSE9859 datasets and MatInspector.
Conditions TF Intersections
No estrogen vs. Era tr./w. estrogen (GSE9757) TF ERG1,ELF3, NR2F6,KLF9
No estrogen vs. Era(def) tr./w. estrogen (GSE9758) TF Empty
No estrogen vs. ERb tr./w. estrogen (GSE9759) TF ELF3,ESR2
No estrogen vs. ERb(def) tr./w. estrogen(GSE9759) TF ESR2
Table 4. 17 Common genes between reanalyzed GSE11352 datasets and MatInspector
Conditions TF Intersections
No estrogen vs. estrogen for 12h TF ERG3,FOXL1,HEY2,NR5A2,SOX3
No estrogen vs. estrogen for 24h TF ERG3,FOXL1,HEY2,NR5A2,SOX3
No estrogen vs. estrogen for 48h TF ERG3,FOXL1,HEY2,MAFF,NR5AS,SOX3
Table 4. 18: Common genes between reanalyzed GSE11506 datasets and MatInspector
Conditions TF Intersections
No estrogen vs. estrogen for 3h TF ERG3,ELF1,FOXL1,RARA,TGIF2, FOXN1
No estrogen vs. estrogen for 6h TF ERG3
Table 4. 19 Common genes between reanalyzed GSE2251 datasets and MatInspector
Conditions TF Intersections
ER neg. tr./w/o. estrogen vs. ER neg.tr./w. 
estrogen
TF Empty
ER neg. tr./w/o. estrogen vs. Era tr./w. estrogen TF KLF12,ELF3,FOXO1A,HOXD1,PITX1,THRB,
KLF10,NRID1,MAFB
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Table 4. 20: Common genes between reanalyzed GSE4025 datasets and MatInspector
Conditions TF Intersections
Era tr./w/o. estrogen vs. Era tr./w estrogen TF LEBPB,LEBPG,ELF1,FOXM1,ITGB3BP
HMGA1,HOXL4,HOXL6,FOXK2,ILF3,
ATF3,TBX2
Table 4. 21: Common genes between reanalyzed GSE4668 datasets and MatInspector
Conditions TF Intersections
0 pM estrogen vs. 10 pM estrogen TF MAFG,BHLHB3,RUNX1
0 pM estrogen vs. 13 pM estrogen TF MAFG,BHLHB3,RUNX1
0 pM estrogen vs. 16 pM estrogen TF MAFG,BHLHB3,RUNX1
0 pM estrogen vs. 100 pM estrogen TF MAFG,BHLHB3,RUNX1
Table 4. 22: Common genes between reanalyzed GSE4006 datasets and MatInspector
Conditions TF Intersections
Era tr./w/o. estrogen vs. Era 
tr./w. estrogen
TF EGR3,ELF1,ITGB3PB,MAFF,HOXL4,HOXL5,HOXL6,HOXL10,
Sox3,KLF10,KLF4
Erab tr./w/o. estrogen vs. Erab 
tr./w. estrogen (5moi)
TF EGR1,EGR3ELF1,FOXM1,FOXO1A, MAFF, HOXL4, HOXL5,   
HOXL6,HOXL10,NFIL3,Sox3,STAT4,TBX2,KLF10,KLF4
Erab tr./w/o. estrogen vs. Erab 
tr./w. estrogen (50moi)
TF NR2F6,ETS2,HEY1,BCL6, in addition, same factors in the second 
raw
Table 4. 23: Common genes between reanalyzed GSE11324 datasets and MatInspector
Conditions TF Intersections
Estrogen at 0h vs. estrogen at 3h TF ELF1,HEY2,HIF1A,RUNX2
Estrogen at 0h vs. estrogen at 6h TF HEY2,HIF1A,SMARCA3
Estrogen at 0h vs. estrogen at 12h TF ATF2,E2F7,HEY2,HIF1A,ATF1,KLF3,SMARCA3
Sox3,SP3,TAF2,TAF9,TEAD1,E2F8,CLOCK
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5. DISCUSSION
Stem cells are the new hope for the century since they have the potential to 
differentiate to several types of cells and tissues. They are future candidates for many 
therapeutic applications and can be the cure for many diseases such as neurodegenerative 
diseases, diabetes, and cancer (Fuchs and Segre, 2000). MSCs can differentiate to osteoblasts, 
chondrocytes, adipocytes, myocytes, cartilage, tendon, muscle, and fat tissue (Baksh et al, 
2004; Caplan and Bruder, 2001). One of the major issues is that they form a very small 
population of nucleated cells in the bone marrow and their number has to be increased before 
they can be used for therapeutic purposes. There have been many advances to overcome this 
problem by mimicking their niche structure and by giving required factors, and hypoxic 
condition and estrogen are important players in these advances. 
Mesenchymal stem cells are heterogeneous population of cells and are characterized after 
isolation from the bone marrow. MSCs that are cultured in vitro lack specific and unique 
marker. There is a general consensus that MSCs do not express the hematopoietic markers 
CD34 and CD45, whereas they do express variable levels of CD90, CD71 and CD29 (Uncelli 
A. et.al. 2008).   In this respect, it is important to determine whether isolated bone morrow 
cells are MSCs cells indeed because it is possible to isolate rat MSCs with other cell types. 
Therefore, we also characterized the expression of specific markers and, our results showed 
that our cells expressed CD90, CD71 and CD29 but not CD34 and CD45, indicating that our 
14th day cells are MSCs. However, we cannot rule out the presence of small population of 
other cells because it is hard to obtain pure MSCs population (Uncelli A. et. al. 2008).
Hypoxia is one of the important environmental factors that plays role in the development, 
in disease formation and stem cell biology. It has been showed that hypoxic stimuli are 
important for the stem cell behavior (Spradling A. et. al 2001). It is believed that most of the 
niche structure where stem cells reside are quite hypoxic, which might be important to prevent 
stem cells from oxygen species, which then harm the DNA and cause formation of cancer 
stem cell (Parmar K. et. al. 2007). In addition, hypoxia can regulate cellular differentiation. 
Under hypoxic condition, the differentiation of embryonal stem cells is inhibited (Kile M. et 
al. 2005). Hypoxia also keeps their “stemness” feature, although its role is not fully 
understood (Lin Q. et. al. 2006). Bone morrow isolated MSCs cannot differentiate into 
adipocytes and chondrocytes when they are in hypoxic condition. The bone marrow 
microenvironment   provides the niche structure for MSCs together with HSC and has lower 
oxygen concentration (Ezashi T. et. al. 2005). 
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Estrogen is another important physiological factor which regulates many pathways 
vital for the homeostasis of the body and its loss or decrease results in serious health problems 
such as osteoporosis, arteriosclerosis, increase in coronary heart diseases and 
neurodegenerative disease (Zhou et al, 2001). It also plays roles in development and 
maintenance of normal sexual and reproductive functions. It has been showed that estrogen is 
important for stem cell biology (Deroo and Korach, 2006). It is known that estrogen can 
enhance the proliferation and migration of some stem cells. Role of estrogen on MSCs 
biology is also known, in which estrogen gives protective role to MSCs in female by 
decreasing pro-inflammatory signals (Ray R et. al. 2008). Besides, it is also known that 
estrogen role in MSCs differentiation into adipogenesis and osteogenesis, while increase the 
proliferation rate of MSCs (Zhou et al, 2001).  
Therefore, we would like to know whether two physiological stimuli play roles in 
MSCs biology by acting together. So far, there has been no study showing the relationship 
between estrogen and hypoxia in MSCs biology. 
In order to reach our aim, we first generated hypoxic condition by using CoCl2, which 
is an iron chelator and inhibits the ferrus state of PHD proteins that are the regulator of HIF1-
alpha transcription factor. Since PHDs are no longer functional, Hif-1alpha escapes the 
posttranslational regulation and goes to nucleus and activates its target genes (Kaelin et. al. 
2008). After hypoxic condition was mimicked, we performed colony forming assay, TUNEL 
assay and BrdU incorporation assay. According to the colony forming assay, the number of 
colonies increased upon CoCl2 treatment when compared with normal samples, which was in 
accordance with result from Grayson et. al.,2007. The number of colonies was further 
increased by addition of estrogen in cells treated with hypoxic condition, suggesting that 
hypoxia led increase in the colony number and the number was further increased upon 
estrogen. Therefore, we can conclude that hypoxic response and estrogen pathway act 
together in MSC expansion. In addition, increase in colony number was also observed in cells 
treated with estrogen alone when compared with the normal cells, which was also shown by 
Zhou et al, 2001. 
Although, we expected to see that the proliferation of MSCs in hypoxic condition was 
also correlated with increase in colony number as in other studies, such as Grayson et. al. 
2006, we could not observe such correlation. The reason for this might be that CoCl2 also 
affected the regulation of proteins playing role in cell proliferation. Since CoCl2 is a heavy 
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metal, it may cause the repression of the activator of cell-cycle protein, which results in low 
rate in proliferation. In fact, most of the low oxygen tension studies were performed by using 
appropriate gas mixture where oxygen level was between 1-2%. However, since estrogen act 
as a growth factor in many cell types (Heldring N. et. al. 2007), it is expected to see that 
estrogen increases the proliferation rate. Indeed, the proliferation was increased again when 
estrogen was added to the cells treated with CoCl2 and this was correlated with what was 
observed in colony forming assay. In addition, addition of estrogen alone to the normal MSCs 
led increase in the proliferation rate, which is in accordance with Zhou et al, 2001. As a result 
we can conclude that estrogen increase the proliferation of MSCs in both hypoxic and 
normoxic condition. 
According to the TUNEL assay, the percentage of apoptosis was increased in hypoxic 
condition when compared to the normoxic cells, and the percentage was decreased when 
samples were treated with the estrogen, indicating that estrogen protects MSCs in hypoxic 
condition from undergoing apoptosis. In addition, Jung J. et. al. 2008 showed that estrodiol 
protects cells against CoCl2 apoptosis, which was correlated with our result. There are 
conflicting results regarding to the effect of hypoxia on stem cells. Some studies stated that 
apoptosis was reduced in different stem cell populations cultured in lower oxygen conditions 
because of fewer reactive oxygen species are generated in culture in low vs. high oxygen
conditions (Grayson W. et. al. 2007; Studer. L. et. al.2000). On the other hand, it has also 
been shown that hypoxia could cause apoptosis due to deprivation of growth factors (Weiquan 
Z. et. al. 2007 & Gui C. et. al. 2007). Our results correlated with the latter one at the hypoxic 
condition, where the percentage of apoptosis was reduced when these samples were treated 
with estrogen.  Another reason why we found high apoptosis in samples treated with CoCl2
was that we used CoCl2, which might cause cellular toxicity and lead increase in apoptosis 
(Hongying R. et. al. 2006). 
As a result, we may conclude that hypoxia and estrogen play synergistic role in 
expansion of MSCs. Our results showed that MSCs cells exhibited high colony number in 
hypoxic conditions and the expansion of MSCs was increased addition of the estrogen. 
Despite the fact that percentage of proliferation was not accordance with in colony formation 
rate, because of the likelihood effect of CoCl2 on cell cycle proteins, increase in the 
proliferation upon estrogen treatment was observed in cells treated with or without CoCl2, 
suggesting that estrogen increases the cell numbers. The increase in the percentage of 
apoptosis was expected because hypoxia also induces apoptosis and CoCl2 might lead to 
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cellular toxicity. Addition of estrogen, however, decreases the pecentage in cells treated with 
or without estrogen, which suggests that estrogen plays a protective role for MSCs in hypoxic 
condition by preventing apoptosis. 
Notch signaling is conserved across metazoan species, operates in most tissues and is used 
at various stages of decision-making in many cell lineages. Notch pathway is also important 
for stem cell maintenance because it leads to differentiation of one type of stem or progenitor 
cells into their specific lineages, while prevent the differentiation of others, and keep them in 
a self renewal state. Notch signaling was also important factors for niche structures and thus, 
important for the determination of fate of the stem cells reside in niche structure (Simon & 
Keith , 2008). 
In the canonical Notch pathway, the single-pass transmembrane cell surface receptors 
(Notch 1–4 in mammals) undergo two sequential proteolytic cleavages upon binding of its 
ligands (Jagged-1 and Jagged-2 and Delta-like-1, Delta-like-3 and Delta-like-4 in mammals) 
presented on a neighboring cell surface. As a result, the Notch intracellular domain (NICD) is 
released from the plasma membrane and translocates to the nucleus, where it interacts with a 
transcription factor of the CSL family (RBP-Jk or CBF-1 in mammals) to activate 
transcription of target genes ( Hilton M. et. al. 2008).
There is a relationship between notch signaling and hypoxia. Some hypoxic effects on 
progenitor cells correlate with the effects of Notch signalling in these cells. Gustaffson et al. 
have shown that hypoxia directly influences Notch activity. Hypoxia (1% O2), through the 
accumulation of HIF-1α, blocks the myogenic differentiation of C2C12 myoblast cells and the 
neuronal differentiation of P19 embryonic carcinoma cells. The authors propose a model in 
which HIF-1α interacts with Notch–CSLtranscriptional complexes at Notch-responsive 
promoters in hypoxic cells to control the differentiation status of myogenic and neuronal 
precursors (Simon C. & Keith B 2008). However, there is no direct relationship between 
notch signaling and the estrogen. All data regarding with estrogen and notch comes from the 
breast cancer, in which the expression of notch receptor and presence of estrogen are in 
reverse relation. 
Therefore, we tried to investigate how expression levels of notch receptors were 
changed when cells treated with CoCl2 because there is no direct information whether 
expression of notch receptors are increased upon hypoxic condition. We also tried to 
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understand whether estrogen affects the expression level of notch receptors in normoxia and 
hypoxic condition. 
In order to reach our purpose, we investigated the expression level of Notch receptors 
in mRNA and protein level. According to RT-PCR results, expression level of Notch-1 did 
not changed in CoCl2 treatment. The only change that we observed was that its expression 
level appeared to be decreased in normal samples treated with estrogen. Therefore, we can say 
that estrogen might decrease the expression level of Notch-1. Unfortunately, we cannot 
confirm this data in the protein level because there were not any western blot data because 
antibodies could not work for unknown reason. Besides, immunohiscochemistry result of 
Notch 1 indicated that expression level of Notch 1 increased upon CoCl2 treatment, which is 
not correlated with the PCR data. In addition immunohistochemistry does not enough to show 
how estrogen affects the Notch-1 expression. As a result, even if we can say that estrogen 
might decrease the expression of Notch 1, these data is not enough to draw such a conclusion.
The information about the expression of Notch 2 came from the PCR result and its 
expression did not changed upon CoCl2 treatment and estrogen treatment. In addition, there 
was no protein data about Notch 2 because there was no primary antibody for Notch 2. 
Therefore, we cannot say much about how hypoxia and estrogen affects the expression level 
of Notch 2.
The expression level of Notch 3 did not changed upon CoCl2 treatment. Its expression 
appeared to be decreased when normal samples were treated with estrogen as in Notch 1. The 
protein expression seemed increase in cells treated with CoCl2, but we could not say about the 
effects of estrogen because no western blot data could obtain because of the problem in work 
of primary antibody. The change in the expression level of Notch 3 was not correlated 
between mRNA and protein level. Therefore, it is hard to assume whether hypoxia and 
estrogen influence the notch expression in MSCs. 
Notch 4 expression, however, exhibited more changes upon CoCl2 treatment and 
estrogen treatment when compared with other notch receptors according to the PCR result. 
The expression level of Notch 4 was increased in hypoxic condition, which was accordance 
with the immunofluorescence, where its expression level was increased upon CoCl2treatment. 
In addition, addition of estrogen to the samples led further increase in Notch 4 expression in 
cells treated with or without CoCl2. Unfortunately, this was not confirmed by western blot 
because the Notch 4 primary antibody could not work. As a result, we can suggest that 
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hypoxia and estrogen have role in controlling the expression of Notch 4 expression, but 
further confirmation should be certainly done because the data are not enough to draw such a 
conclusion.    
Consequently, we can conclude that the level of Notch 4 changed upon CoCl2
treatment and show similar pattern with the protein level, and estrogen also increase the 
expression of Notch 4. We can also conclude that expression level of Notch 1, Notch 2 and 
Notch 3 did not change with CoCl2 treatment. Its level was decreased in normal samples when 
treated with estrogen. Unfortunately, there is no appropriate protein data to support the 
assumption. In addition, there was disparity between mRNA and protein expression in Notch 
1 and Notch 3, suggesting a possible posttranscriptional modification.  
We also investigated the effects of estrogen on notch receptor expression by in silico
analysis. In this time, we were not interested whether estrogen exerts its effect via ER and 
ER receptor, instead we tried to detect if the expression level of notch receptor changed by 
other transcription factors whose expression are induced by estrogen. In order to reach our 
aim, transcription factors that bind to regulatory region of Notch 1 receptor were examined.
We investigated Notch 1 because it was known that its expression was increased upon 
estrogen treatment in MCF-7 cells lines (Soares R. et.al.2004). Since most of the promoter 
region resides in 5’ UTR region of the genes, we found 10000bp upstream sequence of Notch 
1 from the first exon by using BioMart. The sequence then was entered to the MatInspector 
data base, which was developed for finding to transcription factor binding to given sequence
(Cartharius et al., 2005). Transcription factors were selected according to their core and 
matrix similarity values which were between 0.9 and 1 as indicated by Cartharius et al., 2005. 
Twelve microarray datasets were reanalyzed by BrB tools. From the analysis, estrogen up-
regulated genes were selected from each reanalyzed microarrays according to the 
experimental setups which was described in the result. Differentially expressed genes were 
selected after one-way ANOVA was performed. In order to combine the data obtained from 
MatInspector and obtained from reanalyzed microarray datasets, common genes were found 
by using Webgestalt tools. As a result of these common genes, we concluded that these 
transcription factors were upregulated upon estrogen treatment and they had the ability to bind 
to the 5’ UTR of region Notch 1, suggesting that these transcription factors may be 
responsible for the Notch 1 expression upon estrogen treatment. These should be checked by 
wet-lab experiments for further studies. The intersection of these common genes was also 
investigated, and we found that ERG family transcription factors, ELF family transcription 
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factors, HOXL4 family transcription factors, KLF family transcription factors and 
transcription factors SOX3 were common, indicating that further characterization of these 
factor may be important to understand the relationship between estrogen and notch signaling. 
Besides, KLF family transcription factors and Sox3 might be more important because it has 
been known that Sox-2 and KLF-4 were essential player in stem cell biology in which they 
required for stem cell pluripotency (Keith B. et. al. 2007). Therefore, it is interesting to 
investigate these families in our system. We believed our results were significant because we 
reanalyzed 12 microarrays datasets performed with different cell lines, with different 
concentration of estrogen and with different incubation times. . We also believe that 
transcription factors found by MatInspector did not contain false positive results because we 
selected the factors according to their core and matrix similarity values. 
Despite the fact that physiological stimulus are important for MSCs maintenance, 
extra cellular components of the niche structure are also important for MSC behavior. Tissue 
engineering has become one of the leading areas, in which an in vivo local environment that 
enables cells to promote their proliferation and differentiation is created by making use of 
biomaterials and technologies (Tabata Y. 2009).  Biomaterials play a key role in designing 
and creating substitutes for ECM, which is important for cell proliferation and differentiation 
because it provides the living place of cells and biosignalling molecules as the nutrients of 
cells. In addition to therapeutic applications, biomaterials are also useful in the progress of 
research and development of stem cell biology and medicine (Tabata Y. 2009). 
In these regards, we tried to expand female rat bone marrow MSCs on twenty different 
biomaterials, which were produced combinations of different polymer described in the 
materials and method section. Our purpose was to distinguish which biomaterials were 
suitable for MSCs attachment and maintenance, but not for the other cell types coming from 
the bone marrow. In order to determine this, we investigated whether MSCs were able to 
attach the biomaterials after 14 days of culture by checking the morphology of the cells and 
by the colony forming assay. 
Our results showed that MSCs were able to form colonies on some of the 
biomaterials. We observed MSCs on biomaterials designated as CIII-1, CIII-2 CIII-3, CIII-5, 
CI-K, CI-A, CA-1 and CA-2. Among them only on biomaterial CIII-3, MSCs did not from 
colonies shown by CFU-F.  Biomaterials CA-1, CA-2,  CA-3, CI-K,CI-A, CIII-1, CIII2 and 
CIII-5 supports the attachment and growth of the MSCs-like cells as indicated in colony 
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formation and cell morphology. We can also conclude that cells grown on CI-K, CIII-1, CIII-
2 and CIII-5 are more appropriate materials to use in expanding MSCs because no other cells 
attached to them. 
In addition, we can also conclude that the combination of polymers designated as 
HEMA/HPC is appropriate in the proportion of 1:0 (CI-K) and 2:1(CI-A). The combination 
polymers designated as HPMA/PEG provided appropriate conditions when prepared in the 
proportion of 1:0 (CA-1), 1:1 (CA-2) and 2:1 (CA-3). The appropriate proportion of polymers 
designated as HEMA/PEG/HPC was 2:1:1(CIII-1), 3:0:1 (CIII-2) and 1:1:0 (CIII-5). The 
combination of polymers designated as HPMA, PEG and HPC did not provide suitable 
condition for MSCs. Moreover, different derivatives of HEMA and HPMA might be used in 
order to produce more suitable biomaterials because it was shown that modified HEMA or 
modified HPMA provided a good condition for MSCs isolated from the rat bone marrow, 
which then was used for the treatment of spinal cord injury (Sykova E. et. al 2006).
Modification of PEG polymer might also improve the attachment of MSCs on biomaterials 
designated as C, and as CII (Lin C. et.al. 2008). However, although colony forming is one of 
the important features of MSCs cells and might give better insight whether cells are MSCs, 
specific markers should also be controlled for better characterization. It should be also noted 
that some biomaterials might toxic to the cells or they not allow to diffusion of nutrients and 
waste product of cells to the medium (Sridharan et. al. 2009) because of the combination of 
different polymer, which might be the reason of problem in observation of cells grown in 
some biomaterials. In addition, visualization became a big problem when investigating 
biomaterials, which may be result from the chemical composition of the polymers. 
In general, we conclude that hypoxia and estrogen are required environmental factors 
for MSCs biology and estrogen might play a protective role in MSCs by inhibiting apoptosis 
in hypoxic condition. In addition, according to the bio informatics analysis, ERG family 
transcription factors, ELF family transcription factors, HOXL4 family transcription factors, 
KLF family transcription factors and SOX3 were upregulated upon estrogen and then they 
might bind to the Notch 1 transcriptional regulatory region. Lastly, biomaterials, designated as 
CA-1, CA-2, CA-3, CI-K, CI-A, CIII-1, CIII-2 and CIII-3, were appropriate candidates to 
expand MSCs cells and further studies. 
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6. FUTURE PERSPECTIVES
Since we hypothesizes that hypoxia and estrogen are essentials factors for MSCs 
expansion and since we speculate that estrogen prevent apoptosis in MSCs in hypoxic 
conditions, some further studies can be performed . The cell cycle stages of MSCs can be 
investigated in hypoxic condition with or without estrogen treatment in order get more 
information about how estrogen and hypoxia affect the proliferation of MSCs. In addition, the 
expression level of cell cycle protein can also be investigated. The role of estrogen in both 
pro-apoptotic and anti apoptotic genes can be investigated in hypoxic condition. The 
expression level of these genes can be checked in MSCs in hypoxic conditions with or 
without estrogen treatment. Since MSCs are multipotent stem cells, the effects of hypoxia and 
estrogen can be determined in MSCs differentiation. However, in this time it is better to use 
the appropriated gas mixture because differentiation assay takes long times, and addition of 
excess CoCl2 may cause toxicity to cells. By analyzing the how differentiation of MSCs to 
adipogenesis and osteogenesis changes in hypoxia with or without estrogen gives important 
understanding about MSCs expansion upon physiological stimuli. 
The effect of estrogen on notch expression can also be investigated. Common 
transcription factors found by in silico analysis can be controlled one by one. In order to 
confirm the results, Chip assay can be performed whether these genes bind to the Notch 
regulatory regions. Reporter gene assay can also be performed to confirm this. The expression 
level of these factors can be checked upon estrogen treatment to confirm the bioinformatics 
data. In addition, the effect of estrogen on ADAM-10 metalloproteinase expression can also 
be investigated because ADAM family proteins play a role in notch receptor cleave, and thus 
activation. Therefore, this might reveal another mechanism in the regulation of Notch receptor 
by estrogen.
The features of biomaterials used in our study can be improved. The composition of 
the polymer can be changed, and other molecules can be used to get better bio materials such 
as ECM components. Besides, effects of estrogen can be investigated when cells grown on the 
biomaterials. Since estrogen is one of the growth factors, its presence might increase the 
expansion of MSCs when grown on them. Since visualization poses a problem in taking the 
pictures, other chemicals can be added in the process of polymerization. Furthermore, MSC-
like cells grown on them should be characterized by looking the expression of specific 
markers of MSCs.      
87
7. REFERENCES
Armstrong L., Lako M., Lincoln J., Cairns P. M., and Hole N. (2000). mTert expression 
correlates with telomerase activity during the differentiation of murine embryonic stem 
cells. Mechanisms of Development. 97(1-2):109-116.
Artavanis-Tsakonas S., Rand M.D. and Lake R.J. (1999). Notch signaling: cell fate control 
and signal integration in development. Science. 284: 770–776
Badge R. L. (2001). The future for stem cell research. Nature. 414:88-91.
Barry F. P., and Murphy J. M. (2004). Mesenchymal stem cells: clinical applications and 
biological characterization. The International Journal of Biochemistry & Cell Biology. 
36(4):568-584
Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T. (2008). Efficient homing of 
multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of 
CCR2. Cell Stem Cell 2: 566-575.
Bianco P, Robey PG, Simmons PJ. (2008). Mesenchymal stem cells: Revisiting history, 
concepts, and assays. Cell Stem Cell 2: 313-319.
Brahimi-Horn C, Mazure N, and Pouyssegur J (2005) Signalling via the hypoxia-inducible 
factor-1alpha requires multiple posttranslational modifications. Cell Signal 17: 1-9.
Brahimi-Horn C, Mazure N, and Pouyssegur J (2007). Oxygen, a source of life and stress. 
FEBS Letter, 582, 3582-3591.
Bray, S.J. (2006). Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. 
Cell Biol. 7: 678–689
Burdon T., Smith A., and Savatier P. (2002). Signalling, cell cycle and pluripotency in
embryonic stem cells. Trends in Cell Biology. 12(9):432-438.
C. Sahlgren, M.V. Gustafsson, S. Jin, L. Poellinger and U. Lendahl. (2008). Notch signaling 
mediates hypoxia-induced tumor cell migration and invasion, Proc Natl Acad Sci U S A
105: 6392–6397
Caplan AI. (1994). The mesengenic process. Clin Plast Surg 21: 429-435.
88
Carroll JS, Meyer CA, Song J, Li W (2006). Genome-wide analysis of estrogen receptor 
binding sites. Nat Genet; 38: 1289-97.
Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein 
M, Werner T. (2005). MatInspector and beyond: promoter analysis based on transcription 
factor binding sites. Bioinformatics, 21:2933-42.
Chang EC, Frasor J, Komm B, Katzenellenbogen BS (2006). Impact of estrogen receptor 
beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Endocrinology, 147 :4831-42.
Cipolleschi MG, Rovida E, Ivanovic Z, Praloran V, Olivotto M, Dello Sbarba P. (2000). The 
expansion of murine bone marrow cells preincubated in hypoxia as an In vitro indicator 
of their marrow- repopulating ability. Leukemia. 14: 735–739.
Coser KR, Chesnes J, Hur J, Ray S (2003). Global analysis of ligand sensitivity of estrogen 
inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray.
Proc Natl Acad Sci, 100
Crews ST (1998) Control of cell lineage-specific development and transcription by 
bHLH-PAS proteins. Genes Dev 12: 607-620.
Crisostomo PR., Meijing W., Christine H., Morrell E.D., Seshadri P., Meldrum K.K., 
Meldrum D.R (2006). Sex dimorphisms in activated mesenchymal stem cell function.
Shock. 26: 571–4.
Crisostomo PR., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. (2008). Human 
mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth 
factors by an NF kappa B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol.
294: 675–682
Csete M. (2006). Oxygen in the Cultivation of Stem Cells. Stem Cell Biology: Development 
and Plasticity, 1049: 1-8.
Dayan F., Roux D.,. Brahimi-Horn M.C, Pouyssegur J. and Mazure N.M. (2006). The oxygen 
sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes 
through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha, 
Cancer Res. 66: 3688–3698.
89
Deroo B. J., and Korach K. S. (2006). Estrogen receptors and human disease. The Journal 
of Clinical Investigation. 116(3):561-570.
Digirolamo C. M., Stokes D., Colter D., Phinney D. G., Class R., and Prockop D. J. (1999).
Propagation and senescence of human marrow stromal cells in culture: a simple colony-
forming assay identifies samples with the greatest potential to propagate and 
differentiate. British Journal of Haematology. 107(2):275-281.
D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. (2004). Marrow-
isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal 
young and old human cells with extensive expansion and differentiation potential. J Cell 
Sci 117: 2971-2981.
Docheva D, Popov C, Mutschler W, Schieker M (2007). Human mesenchymal stem cells in 
contact with their environment: surface characteristics and the integrin system. J. Cell. 
Mol. Med. 11, 21–38
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, 
Keating A, Prockop D, Horwitz E. (2006). Minimal criteria for defining multipotent 
mesenchymal stromal cells. The International Society for Cellular Therapy position 
statement. Cytotherapy 8: 315-317.
Evans M. J., and Kaufman M. H. (1981). Establishment in culture of pluripotential cells 
from mouse embryos. Nature. 292(5819):154-156.
Ezashi T, Das P, Roberts RM. (2005). Low O-2 tensions and the prevention of 
differentiation of hES cells. Proc Natl Acad Sci USA. 102: 4783–4788.
Feng B, Ng J.H (2009). Molecules that Promote or Enhance Reprogramming of Somatic 
Cells to Induced Pluripotent Stem Cells. Cell Stem Cell, 4:301:312.
Fernyhough M.E, Hausman G.J, Guan L.L, Okine E, Moore S.S, Dodson M.V (2008)
Mature adipocytes may be a source of stem cells for tissue engineering. Biochem. 
Biophys. Res. Commun. 368, 455–457
Fink T, Abildtrup L, Fogd K, Abdallah BM, Kassem M, Ebbesen P, Zachar V. (2004). 
Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. 
Stem Cell. 22: 1346–1355.
90
Fortini, M. E. (2002). -secretase-mediated proteolysis in cell-surface-receptor signalling. 
Nature Rev. Mol. Cell Biol. 3: 673–684 
Fortini M. E.. (2009)  Notch Signaling: The Core Pathway and Its Posttranslational 
Regulation. Developmental cell, 16: 633-647
Frasor J, Chang EC, Komm B, Lin CY (2006). Gene expression preferentially regulated by 
tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res, 66: 
7334-40
Friedenstein AJ, Piatetzky S II, Petrakova KV. (1966.) Osteogenesis in transplants of bone 
marrow cells. J Embryol Exp Morphol 16: 381-390. 
Fryer, C. J., White, J. B. & Jones, K. A. (2004). Mastermind recruits CycC–CDK8 to 
phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 16: 
509–520 
Fuchs E., Tumbar T., and Guasch G. (2004). Socializing with the neighbors: stem cells and 
their niche. Cell. 116(6):769-778.
Gilboa L., and Lehmann R. (2004). How different is Venus from Mars? The genetics of 
germ-line stem cells Drosophila females and males. Development. 131(20):4895-4905.
Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T. (2006). Effects of hypoxia on human 
mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol. 207: 
331–339
Grayson WL, Zhao, F, Bunnell B, Ma T. (2007). Hypoxia enhances proliferation and tissue 
formation of human mesenchymal stem cells. Biochem Biophys Res Commun.358: 948–
953.
Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. (2003). 
Molecular and cellular characterisation of highly purified stromal stem cells derived 
from human bone marrow. J Cell Sci 116: 1827-1835.
Gustafsson M.V., Zheng X., Pereira T.,. Gradin K, Jin S., Lundkvist J., Ruas J.L., Poellinger 
L., Lendahl U. and Bondesson M.. (2005). Hypoxia requires notch signaling to maintain 
the undifferentiated cell state. Dev. Cell 9. 617–628.
91
H. Diez, A. Fischer, A. Winkler, C.J. Hu, A.K. Hatzopoulos, G. Breier and M. Gessler. 
(2007). Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial 
progenitor cells and adoption of arterial cell fate. Exp Cell Res 313: 1–9
Hayashi S., Niwa T.and Yamaguchi Y. (2008). Estrogen signaling pathway and hormonal 
therapy. Breast Cancer. 15-256-61.
Hayashi S., Niwa T.and Yamaguchi Y. (2009). Estrogen signaling pathway and its imaging 
in human breast cancer. Cancer Science. (Ahead of print).
Hong L, Colpan A, Peptan IA. (2006) Modulations of 17-beta estradiol on osteogenic and 
adipogenic differentiations of human mesenchymal stem cells. Tissue Eng.12:2747–53.
Horwitz E. M. (2003). Stem cell plasticity: the growing potential of cellular therapy. 
Archives of Medical Research. 34:600-606.
I.M. Conboy, M.J. Conboy, G.M. Smythe and T.A. Rando. (2003). Notch-mediated 
restoration of regenerative potential to aged muscle. Science 302: 1575–1577.
Ivanovic Zoran. (2009). Hypoxia or in situ normoxia: The stem cell paradigm. Journal of 
Cellular Physiology 219: 271-275.
J.Y. Rho, K. Yu, J.S. Han, J.I. Chae, D.B. Koo, H.S. Yoon, S.Y. Moon, K.K. Lee and Y.M. 
Han (2006). Transcriptional profiling of the developmentally important signalling 
pathways in human embryonic stem cells, Hum Reprod 21:
Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ, and 
Kim KW (2002) Regulation and destabilization of HIF-1alpha by ARD1-mediated 
acetylation. Cell 111: 709-720.
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes 
M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, 
Verfaillie CM. (2002). Pluripotency of mesenchymal stem cells derived from adult 
marrow. Nature 418: 41-49.
92
Jung JY, Roh KH, Jeong YJ, Kim SH, Lee EJ, Kim MS, Oh WM, Oh HK, Kim WJ. (2008). 
Estradiol protects PC12 cells against CoCl2-induced apoptosis. Brain Res. Bull, 76: 579-
85.
Kaelin W.G.(2005) Proline hydroxylation and gene expression, Annu. Rev. Biochem.
74:115–128.
Kaelin W. G., and Ratcliffe P. J. (2008). Oxygen Sensing by Metazoans: The Central Role 
of the HIF Hydroxylase Pathway. Cell 30:393-402.
Kaidi A, Williams A.C and Paraskeva C.. (2007). Interaction between beta-catenin and 
HIF-1 promotes cellular adaptation to hypoxia, Nat. Cell Biol. 9: 210–217
Kazi A.A. and Koos R.D.. (2007).  Estrogen-induced activation of hypoxia-inducible 
factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus 
are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 148: 
2363–2374
Ke Q., and Costa M.. (2006). Hypoxia- Inducible Factor-1 (HIF-1). Molecular
Pharmacology 70:1469-1480.
Keith B and Simon MC (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell.
129: 465–472.
Kronblad, A., Hedenfalk, I., Nilsson, E., Pahlman, S. and Landberg, G. (2005) ERK1/2 
inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced 
downregulation of ERalpha: a combination therapy potentially targeting hypoxic and 
dormant tumor cells. Oncogene 24: 6835–6841.
Lando D, Peet DJ, Whelan DA, Gorman JJ, and Whitelaw ML (2002) Asparagine 
hydroxylation of the HIF transactivation domain a hypoxic switch. Science (Wash DC)
295: 858-861
Lin C, Anseth K. (2008). PEG Hydrogels for the Controlled Release of Biomolecules in 
Regenerative Medicine. Journal of the American Association of Pharmaceutical Scientists: 
26-631-643.
Lin CY, Vega VB, Thomsen JS, Zhang T (2007). Whole-genome cartography of estrogen 
receptor alpha binding sites. PLoS Genet. 6:e87.
93
Lin Q, Lee Y, and Yun Z (2006). Differentiation Arrest by Hypoxia. The Journal of 
Biological Chemistry, 281: 30678-83
Lin Z, Reierstad S, Huang CC, Bulun SE (2007). Novel estrogen receptor-alpha binding 
sites and estradiol target genes identified by chromatin immunoprecipitation cloning in 
breast cancer. Cancer Res, 67: 5017-24
Liu Z., Zhuge Y., Velazquez O. C.. (2009). Trafficking and differentiation of 
mesenchymal stem cells. Journal of Cellular Biochemistry 106: 984-991.
Lord BI. (1990). The architecture of bone-marrow cell-populations. Int J Cell Cloning. 8: 
317–331
Lutolf M.P, Hubbell J.A. (2005). Synthetic biomaterials as instructive extracellular 
microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47–55
Ma T., Grayson W.L., Fröhlich M., Vunjak-Novakovic G. (2009). Hypoxia and Stem Cell-
Based Engineering of Mesenchymal Tissues. American Institute of Chemical Engineers 
Biotechnol. Prog. 25: 32–42.
Martin G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos 
cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the 
National Academy of Sciences of the USA. 78(12):7634-7638
Masson N, Willam C, Maxwell PH, Pugh CW, and Ratcliffe PJ (2001).  Independent 
function of two destruction domains in hypoxia-inducible factor-alpha chains activated 
by prolyl hydroxylation. EMBO (Eur Mol Biol Organ) J 20: 5197-5206
McMahon S., Charbonneau M., Grandmont S., Richard D.E and Dubois C.M.. (2006). 
Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization 
through selective inhibition of PHD2 expression, J. Biol. Chem. 281: 24171–24181.
Minet E, Michel G, Mottet D, Raes M, and Michiels C (2001) Transduction pathways 
involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic Biol 
Med 31: 847-855.
Minguell J. J., Erices A., and Conget P. (2001). Mesenchymal Stem Cells. Experimental 
Biology and Medicine. 226(6):507-520.
94
Moggs JG, Murphy TC, Lim FL, Moore DJ (2005). Anti-proliferative effect of estrogen in 
breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell 
cycle genes. J Mol Endocrinol, 34 :535-51.
Monroe DG, Secreto FJ, Subramaniam M, Getz BJ (2005). Estrogen receptor alpha and 
beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene 
expression in human U2OS osteosarcoma cells. Mol Endocrinol 19:1555-68.
Morgan E Carlson and Irina M Conboy (2007). Regulating the Notch pathway in 
embryonic, adult and old stem cells. Current Opinions in Pharmacology. 7:303-309
Morrison S. J., Shah N. M., and Anderson D. J. (1997). Regulatory mechanisms in stem cell 
biology. Cell. 88(3):287-298.
Nagel, A. C., Tenin G., Bravo-Patino A., Bray S., Maier D., Preiss A.  (2005). Hairless-
mediated repression of Notch target genes requires the combined activity of Groucho 
and CtBP corepressors. Mol. Cell. Biol. 25: 10433–10441 
Nam, Y., Sliz, P., Song, L., Aster, J. C. & Blacklow, S. C. (2006). Structural basis for 
cooperativity in recruitment of MAML coactivators to Notch transcription complexes.
Cell 124: 973–983 
Noggle S.A., Weiler D.and Condie B.G. (2006). Notch signaling is inactive but inducible in 
human embryonic stem cells. Stem Cells 24: 1646–1653
Norman AW, Mizwicki MT, Norman DP. (2004). Steroid-hormone rapid actions, 
membrane receptors and a conformational ensemble model. Nat Rev. 3: 27–41.
Nott SL, Huang Y, Li X, Fluharty BR (2009). Genomic responses from the estrogen-
responsive element-dependent signaling pathway mediated by estrogen receptor alpha 
are required to elicit cellular alterations. J Biol Chem.28:15277-88
Oswald, F., Winkler M., Cao Y., Astrahantseff K., Bourteele S., Knöchel W., Borggrefe T. 
(2005). RBP-J /SHARP recruits CtIP/CtBP corepressors to silence Notch target genes.
Mol. Cell. Biol. 25: 10379–10390 
Page E.L., Chan D.A., Giaccia A.J., Levine M. and Richard D.E.. (2007). Hypoxia-inducible 
factor-1{alpha} stabilization in nonhypoxic conditions: role of oxidation and 
intracellular ascorbate depletion. Mol. Biol. Cell 19: 86–94.
95
Pedersen R. A. (1999). Embryonic stem cells for medicine. Scientific American. 280(4):68-
73.
Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman 
M. A., Simonetti D. W., Craig S., and Marshak D. R. (1999). Multilineage potential of adult 
human mesenchymal stem cells. Science. 284(5411):143-147.
Poellinger L. and Lendahl U. (2008). Modulating Notch signaling by pathway-intrinsic 
and pathway-extrinsic mechanisms. Current Opinion in Genetics & Development 18: 449-
454.
Prelle K., Vassiliev I. M., Vassilieva S. G., Wolf E., and Wobus A. M. (1999). Establishment 
of pluripotent cell lines from vertebrate species--present status and future prospects. 
Cells Tissues Organs. 165(3-4):220-236.
Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, and Ratcliffe PJ (1997) Activation of 
hypoxia-inducible factor-1; definition of regulatory domains within the subunit. J Biol 
Chem 272: 11205-11214.
R. Soares, G. Balogh, S. Guo, F. Ga¨ Rtner, J. Russo, And F. Schmıtt. (2004). Evidence for 
the Notch Signaling Pathway on the Role of Estrogen in Angiogenesis. Molecular 
Endocrinology, 18:2333–2343
Rae JM, Johnson MD, Scheys JO, Cordero KE (2005). GREB 1 is a critical regulator of 
hormone dependent breast cancer growth. Breast Cancer Res Treat, 92 :141-9
Raghunanth J.,Salacinski H., Sales K., Butler P., Seifalian A. (2005). Advancing Cartilage 
Tissue Engineering: the application of stem cell technology. Current Opinion in 
Biotechnology: 16, 503-509.
Rajan A., Tien A., Haueter C.M., Schulze K.L., Bellen H. J. (2009). The Arp2/3 complex 
and WASp are required for apical trafficking of Delta into microvilli during cell fate 
specification of sensory organ precursors. Nature Cell Biology. 11: 815 – 824
Ray R., Novotny N. M., Crisostomo P.R., Lahm T., Abarbanell A., and Meldrum D. R. 
(2008). Sex Steroids and Stem Cell Function. Molecular Medicine. 14: 493-501.
Rizzo P., Miao H., D'Souza G., Osipo C., Yun J. and Zhao H. (2008). Cross-talk between 
notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. 
Cancer Res 68: 5226–5235.
96
Rizzo P., Osipo C., Pannuti A., Golde T., Osborne B. and Miele L. (2009) Targeting Notch 
signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. Advances in 
Enzyme Regulation. 49: 134-141
Ruas JL, Poellinger L, and Pereira T (2002). Functional analysis of hypoxia-inducible 
factor-1 alpha-mediated transactivation. Identification of amino acid residues critical 
for transcriptional activation and/or interaction with CREB-binding protein. J Biol 
Chem 277: 38723-38730.
Salceda S, and Caro J (1997) Hypoxia-inducible factor 1 (HIF-1 ) protein is rapidly 
degraded by the ubiquitin-proteasome system under normoxic conditions. Its 
stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272: 22642-
22647.
Schofield C.J. and Ratcliffe P.J.. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. 
Mol. Cell Biol. 5:343–354.
Seifeddine R., Dreiem A., Tomkiewicz C., Fulchignoni-Lataud M.C., Brito I., Danan J.L., 
Favaudon V., Barouki R. and Massaad-Massade L..(2007). Hypoxia and estrogen co-
operate to regulate gene expression in T-47D human breast cancer cells, J. Steroid 
Biochem. Mol. Biol. 104: 169-179.
Sell S. (2003). Embryonic stem cells: Isolation and application of pluripotent cells from 
the pregastrulation mammalian embryo. Rathien J., and Rathien P.D. Stem Cell Handbook.
Humana Press Inc, NJ.
Semenza GL, Nejfelt MK, Chi SM, and Antonarakis SE (1991) Hypoxia-inducible nuclear 
factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc 
Natl Acad Sci USA 88: 5680-5684
Serakinci N., and Keith W. N. (2006). Therapeutic potential of adult stem cells. European 
Journal of Cancer. 42(9):1243-1246.
Sherley J. L. (2002). Asymmetric cell Kinetics Genes: the key to expansion of adult stem 
cells in culture. Stem Cells. 20(6):561-572.
Simon M.C and Keith B. (2008). The role of oxygen availability in embryonic 
development and stem cell function. Nature Rewievs Molecular Cell Biology, 9: 285-296.
97
Smith CL and O’Malley BW. (2004). Coregulator function: a key to understanding tissue 
specificity of selective receptor modulators. Endocr Rev. 25: 45–71.
Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. (2004). The role of Shc and 
insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor 
α to the plasma membrane. Proc Natl Acad Sci USA. 101: 2076–81
Stossi F, Barnett DH, Frasor J, Komm B (2004). Transcriptional profiling of estrogen-
regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human 
osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology. 
145:3473-86.
Sykova E, Jendelova P, Urdzikova L, Lensy P, Hejcl A. (2005). Bone Marrow Stem Cells 
and Polymer Hydrogels-Two Strategies for Spinal Cord Injury Repair. Cellular and 
Molecular Neurobiology: 26,1111-1127.
Tabata Y. (2009) Biomaterial technology for tissue engineering applications. J. R. Soc. 
Interface, 4: 311-324.
Takahashi. K, Yamanaka S. (2006). Induction of pluripotent stem cells from mouse 
embryonic and adult fibroblast cultures by defined factors. Cell, 126:663-76
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007). 
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell, 131: 861-72
Thomson J. A., Itskovitz-Eldor J., Shapiro S. S., Waknitz M. A., Swiergiel J. J., Marshall V. 
S., and Jones J. M. (1998). Embryonic stem cell lines derived from human blastocysts. 
Science. 282(5391):1145-1147.
Tian H, McKnight SL, and Russell DW (1997) Endothelial PAS domain protein 1 
(EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:
72-82.
Till J. E., and McCulloch E. A. (1961). A direct measurement of the radiation sensitivity 
of normal mouse bone marrow cells. Radiation Research. 14:213-222.
Toya RE, Barrett JV, Davis ML. (1976). Hypoxia induced proliferation of hematopoietic 
stem-cells in bone-marrow of mice. Radiat Res. 67: 591–591
98
Uccelli A, Moretta L, Pistoia V. (2008). Mesenchymal stem cells in health and disease. Nat. 
Rev. Immunol, 8:726-36
Wang GL, Jiang BH, Rue EA, and Semenza GL (1995) Hypoxia-inducible factor 1 is a 
basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad 
Sci USA 92: 5510-5514.
Wang Q., Jin-Hua Y., Hui-Hong Z., Qing-Tao Z., Chen J. (2006). Temporal expression of 
estrogen receptor alpha in rat bone marrow mesenchymal stem cells. Biochem Biophys 
Res Commun. 347: 117–23
Watt FM and Hogan BLM. (2000). Out of Eden: stem cells and their niches. Science. 287: 
1427–1430.
Weiss L. (1976). Hematopoietic microenvironment of bone-marrow— ultrastructural-
study of stroma in rats. Anat Rec. 186: 161–184.
Weissman I.L. (2000). Stem Cells: Units of Development, Units of Regeneration, and 
Units in Evolution. Cell. 100: 157-168
Wilsona A. and Radtke F. (2006). Multiple functions of Notch signaling in self-renewing 
organs and cancer. Federation of European Biochemical Societies. 580: 2860–2868
X. Zheng, S. Linke, J.M. Dias, X. Zheng, K. Gradin, T.P. Wallis, B.R. Hamilton, M. 
Gustafsson, J.L. Ruas and S. Wilkins (2008). Interaction with factor inhibiting HIF-1 
defines an additional mode of cross-coupling between the Notch and hypoxia signaling 
pathways. Proc Natl Acad Sci U S A 105: 3368–3373.
Xu C., Inokuma M. S., Denham J., Golds K., Kundu P., Gold J. D., and Carpenter M. K. 
(2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature 
Biotechnology. 19(10):971-974.
Yamanaka Shinya (2009). A Fresh Look at iPS cells. Cell, 137: 13-17.
Yi J.M., Kwon H.Y, Cho J.Y. and Lee Y.J. (2009). Estrogen and hypoxia regulate estrogen 
receptor alpha in a synergistic manner. Biochemical and Biophysical Research 
Communications. 378: 842-846
99
Zhang B, Kirov S, Snoddy J.(2005). WebGestalt: an integrated system for exploring gene 
sets in various biological contexts. Nucleic Acids Res, 33: 741-8.
100
8. APPENDICES
Appendix A
Standard Solutions and Buffers
DEPC-Treated ddH2O 
1ml DEPC
1lt ddH2O
Stirred in a hood for 1 hour, autoclaved in order to inactivate the DEPC
10x PBS
80 g NaCl
2 g KCl
8,01g Na2HPO4.2H2O
2g KH2PO4
1 liter ddH2O pH: 7,2
Working solution (1XPBS) was prepared by diluting 10XPBS by 10 times
50X TAE Buffer
2M Tris Base (242 g)
57,1 ml Glacial Acetic Acid
50mM EDTA
Add to 1 lt by ddH2O
Working solution (1XTAE) prepared by diluting 50XTAE by 50 times
10 X Agarose Gel Loading Dye
0,009g BFB
0,009g XC
2,8mL ddH2O
1,2ml 0,5M EDTA.
Total volume brought to 15ml by adding glycerol, dilute 1:10 in sample prior to 
loading to electrophoresis gel
101
Cold 70% Ethanol
70 ml Ethanol 
30 ml ddH2O
Dissolved and keep at 4 C
4% PFA
4g PFA 
100ml 1XPBS 
Dissolved by heating, solution prepared freshly
10%SDS
100g SDS 
1lt ddH2O
1M Tris
60.55g Tris 
300ml ddH2O
21ml 37% HCl
pH adjusted to 8.0 with HCl, total volume brought to 500ml by adding ddH2O.
0.5M EDTA
93.05g EDTA 
300ml ddH2O
pH adjusted to 8.0 with NaOH, total volume brought to 500ml by adding ddH2O.
30% Acrylamide Mix
145g Acrylamide 
5g bis-acrylamide
500ml ddH2O
Filtered, stored in dark at 40C.
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SDS-PAGE Running Buffer (5X stock solution)
15g Tris
73,2g Glycine
5g SDS
1lt ddH2O
1X working solution prepared by diluting the 5X SDS-PAGE running buffer 5 times, 
stored at 40C
Bradford Reagent
100 mg Coomassie Brilliant Blue G-250 
100 ml 85%phosphoric acid
50 ml 95%EtOH
850 ml ddH2O
Filtered through Whatman no:1
Lysis Buffer
2M NaCl
1M Tris pH:8.2
0.9% Igepal CA-630 (Sigma, Germany)
10x Protease Inhibitor Cocktail (Roche, Germany)
778.5µl ddH2O
10X TBS
12.19 g Tris
87,76 g NaCl
pH adjusted to 8, total volume brought to 1lt by adding ddH2O
1X TBS-T 0.3%
50 ml 10X TBS
450 ml ddH2O
1,5 ml Tween-20
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Total volume brought to 500ml by adding ddH2O
Blocking Solution for Western Blot (5%)
2,5 g milk powder
50mL 1X TBS-T
5% BSA Solution
0.5g BSA
10mL 1X TBS
20 µl tween-20
Blocking Solution for Immunohistochemistry and Immunoflourescence Staining
4 µl 2% BSA
4 µl 1X PBS
20 µl tween-20
Block Solution for BrdU incorporation assay
1.5g BSA
50mL 1X PBS
50 µl tween-20
Cracking Buffer (2X Protein Loading Buffer)
50mM Tris HCl pH: 6,8
2mM EDTA pH: 6,8
1% SDS
20% Glycerol
0,02% BFB
Add 1% ß-mercaptoethanol prior to use
Coomassie Blue Staining Solution:
0,25 g coomassie brilliant blue
45 ml Methanol
45 ml ddH2O
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10 ml glacial acetic acid
5X Running Buffer
15 g Tris base
72 g Glycine
5 g SDS
1 liter ddH2O
Diluted to 1X prior to use
Semi-dry Transfer Buffer
2,5 g glycine
5,8 g Tris base
0,37 g SDS
200 ml methanol
800 ml ddH2O
Destaining Solution
100 ml methanol
35 ml acetic acid
365 ml ddH2O
1 µM CoCl2 stock solution
0.02g CoCl2
10ml ddH2O
2N HCl solution
16.38µl ddH2O
4.3µl HCl at 37 oC
